[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 2386
1. Jardelino C, Takamori ER, Hermida LF, Lenharo A, Castro-Silva II, Granjeiro JM: Porcine peritoneum as source of biocompatible collagen in mice. Acta Cir Bras; 2010 Aug;25(4):332-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Porcine peritoneum as source of biocompatible collagen in mice.
  • PURPOSE: To investigate the biocompatibility and biodegradability of a membrane made from porcine peritoneum.
  • CONCLUSION: The collagen membrane derived from porcine peritoneum is biocompatible and bioabsorbable when implanted in the subcutaneous tissue of mice.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20676490.001).
  • [ISSN] 1678-2674
  • [Journal-full-title] Acta cirurgica brasileira
  • [ISO-abbreviation] Acta Cir Bras
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Biocompatible Materials; 0 / Membranes, Artificial; 9007-34-5 / Collagen
  •  go-up   go-down


2. Viana Ade T, Daud FV, Bonizzia A, Barros PH, Gouvêa ES: Comparative study between parietal peritoneum suture and nonsuture in midline laparotomies in rats. Acta Cir Bras; 2008 Jul-Aug;23(4):348-51
MedlinePlus Health Information. consumer health - Peritoneal Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative study between parietal peritoneum suture and nonsuture in midline laparotomies in rats.
  • PURPOSE: Compare the parietal peritoneum suture and nonsuture in midline laparotomies in rats, as for the formation of adhesions.
  • After anesthesia, a midline laparotomy was performed, followed by cavity closure with and without peritoneum suture.
  • After 40 days, the rats underwent a new surgery in order to verify the peritoneum and check if there were any adhesions, and the rats were then sacrificed.
  • RESULTS: Statistical analysis showed there was no significant difference between the adhesions occurring or not with peritoneal suture or nonsuture, including in relation to the rats' gender.
  • CONCLUSION: Closing the peritoneum or not does not interfere with the formation of adhesions after midline laparotomies in rats from both genders.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18641805.001).
  • [ISSN] 1678-2674
  • [Journal-full-title] Acta cirurgica brasileira
  • [ISO-abbreviation] Acta Cir Bras
  • [Language] ENG
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


3. Doret M, Gaucherand P: [Closure or non closure of the peritoneum at cesarean section in 2008?]. J Gynecol Obstet Biol Reprod (Paris); 2008 Sep;37(5):463-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Closure or non closure of the peritoneum at cesarean section in 2008?].
  • Non closure of the peritoneum at cesarean is still debatable, despite the national and international guidelines.
  • This review aims at exposing risks and benefits of non closure of the peritoneum, focusing on the peritoneum adhesions.
  • Many studies demonstrated no benefits at peritoneum closure in the duration of surgery, the immediate postoperative period and the short-term complications.
  • However, two randomised controlled trials compared pelvic adhesion in the subsequent c-section, in step with closure or non closure of the parietal and visceral peritoneum at first caesarean.
  • The results showed that non closure of the peritoneum does not increase or even reduce the adhesions risk.
  • As a conclusion, current data are supporting the national and international medical society recommendations about the benefits of the non closure of the peritoneum at caesarean section.
  • [MeSH-major] Cesarean Section / methods. Peritoneal Diseases / etiology. Peritoneal Diseases / prevention & control

  • MedlinePlus Health Information. consumer health - Cesarean Section.
  • MedlinePlus Health Information. consumer health - Peritoneal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18495379.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 35
  •  go-up   go-down


Advertisement
4. Ba-Ssalamah A, Uffmann M, Bastati N, Schima W: [Diseases of the peritoneum and mesenterium]. Radiologe; 2009 Jul;49(7):637-51; quiz 652-4
MedlinePlus Health Information. consumer health - Ultrasound.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diseases of the peritoneum and mesenterium].
  • [Transliterated title] Erkrankungen von Peritoneum und Mesenterium.
  • Peritoneal diseases can be seen in the different imaging modalities either as fluid collections or solid tumors along the ligaments, mesenteries, and spaces of the peritoneal cavity.
  • In this article, a large variety of peritoneal abnormalities such as ascites, peritonitis, intraperitoneal hemorrhage, and both primary and secondary peritoneal tumors are discussed.
  • [MeSH-major] Magnetic Resonance Imaging / methods. Mesentery. Peritoneal Diseases / diagnosis. Tomography, X-Ray Computed / methods. Ultrasonography / methods

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Peritoneal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Zentralbl Chir. 1991;116(4):287-9 [2042420.001]
  • [Cites] Vet Radiol Ultrasound. 2008 May-Jun;49(3):227-32 [18546776.001]
  • [Cites] AJR Am J Roentgenol. 2004 Jul;183(1):118 [15208123.001]
  • [Cites] Am J Surg Pathol. 1994 Jun;18(6):591-603 [8179074.001]
  • [Cites] Radiographics. 2002 Nov-Dec;22(6):1511-5 [12432120.001]
  • [Cites] Radiology. 2003 Jan;226(1):86-94 [12511673.001]
  • [Cites] AJR Am J Roentgenol. 2004 Jun;182(6):1463-7 [15149991.001]
  • [Cites] Surg Endosc. 2004 Jul;18(7):1067-70 [15156385.001]
  • [Cites] Radiat Med. 2007 Aug 1;25(7):364-7 [17705008.001]
  • [Cites] Radiographics. 2007 Nov-Dec;27(6):1693-703 [18025512.001]
  • [Cites] Radiographics. 2007 Jan-Feb;27(1):129-43 [17235003.001]
  • [Cites] Br J Radiol. 2004 Jan;77(913):71-3 [14988144.001]
  • [Cites] J Trauma. 1995 Apr;38(4):630-3 [7723108.001]
  • [Cites] Int J Gynaecol Obstet. 2006 Jun;93(3):267-8 [16687143.001]
  • [Cites] Abdom Imaging. 1995 Sep-Oct;20(5):414-20 [7580774.001]
  • [Cites] Radiology. 2003 Apr;227(1):46-51 [12615997.001]
  • [Cites] J Clin Ultrasound. 2005 Feb;33(2):76-9 [15674838.001]
  • [Cites] Radiographics. 1992 May;12(3):445-65 [1609137.001]
  • [Cites] Radiographics. 2005 May-Jun;25(3):719-30 [15888621.001]
  • [Cites] Eur J Surg. 2001 Oct;167(10):723-7 [11775722.001]
  • [Cites] Intern Med. 2008;47(1):73-4 [18176011.001]
  • [Cites] Radiol Clin North Am. 1994 Sep;32(5):913-32 [8085004.001]
  • [Cites] Am J Surg Pathol. 1997 Apr;21(4):392-8 [9130985.001]
  • [Cites] Radiology. 1984 Nov;153(2):507-10 [6385111.001]
  • [Cites] Radiology. 1970 Jun;95(3):547-54 [5442658.001]
  • [Cites] JBR-BTR. 2000 Aug;83(4):153-5 [11126783.001]
  • [Cites] Radiology. 1992 Oct;185(1):169-72 [1523302.001]
  • [Cites] Abdom Imaging. 2008 Jan-Feb;33(1):87-93 [17632751.001]
  • [Cites] Radiology. 1970 Jul;96(1):15-22 [5420399.001]
  • [Cites] N Engl J Med. 2008 Jul 17;359(3):293 [18635434.001]
  • [Cites] AJR Am J Roentgenol. 2000 Feb;174(2):427-31 [10658720.001]
  • [Cites] Eur Radiol. 2008 Jan;18(1):18-23 [17701040.001]
  • [Cites] Br J Radiol. 2007 Nov;80(959):872-7 [17875592.001]
  • [Cites] Radiographics. 2000 Nov-Dec;20(6):1525-36; discussion 1536-7 [11112806.001]
  • [Cites] J Emerg Med. 1999 Sep-Oct;17 (5):823-6 [10499696.001]
  • [Cites] AJR Am J Roentgenol. 2006 Mar;186(3):703-17 [16498098.001]
  • [Cites] Radiographics. 1992 Jan;12 (1):59-77 [1734482.001]
  • [Cites] Dig Surg. 2000;17(4):323-8 [11053936.001]
  • [Cites] Abdom Imaging. 2003 Jul-Aug;28(4):505-14 [14580093.001]
  • [Cites] Pediatr Radiol. 2002 Feb;32(2):88-94 [11819071.001]
  • [Cites] Radiographics. 2005 Nov-Dec;25(6):1501-20 [16284131.001]
  • [Cites] Australas Radiol. 2002 Mar;46(1):91-6 [11966596.001]
  • [Cites] Gastroenterology. 2007 Jul;133(1):14, 372 [17631124.001]
  • [Cites] Abdom Imaging. 1995 Mar-Apr;20(2):138-40 [7787717.001]
  • [Cites] J Trauma. 1996 Nov;41(5):815-20 [8913209.001]
  • [Cites] Eur J Radiol. 2006 Aug;59(2):284-8 [16580806.001]
  • [Cites] Abdom Imaging. 2006 Sep-Oct;31(5):549-54 [16465576.001]
  • [Cites] AJR Am J Roentgenol. 1991 Jun;156(6):1185-7 [2028864.001]
  • (PMID = 19224192.001).
  • [ISSN] 1432-2102
  • [Journal-full-title] Der Radiologe
  • [ISO-abbreviation] Radiologe
  • [Language] ger
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 49
  •  go-up   go-down


5. Tanaka M, Sawai H, Okada Y, Yamamoto M, Funahashi H, Hayakawa T, Takeyama H, Manabe T: Malignant solitary fibrous tumor originating from the peritoneum and review of the literature. Med Sci Monit; 2006 Oct;12(10):CS95-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant solitary fibrous tumor originating from the peritoneum and review of the literature.
  • BACKGROUND: Solitary fibrous tumor (SFT) is a rare neoplasm frequently involving the pleura.
  • Benign and malignant forms of the tumor occur, the benign variant being three to four times more common than the malignant.
  • CASE REPORT: We present herein a rare case of large malignant solitary fibrous tumor (SFT) originating from the peritoneum.
  • An abdominal computed tomography scan revealed a well-defined solid tumor with mixed density.
  • An abdominal ultrasonography (US) revealed a well-circumscribed solid tumor containing a partially cystic lesion.
  • Liposarcoma originating from the retroperitoneum was suggested, and the patient underwent a complete resection of the tumor as well as the left kidney because tumor invasion of the upper left kidney was suspected.
  • Immunohistochemically, the spindle-shaped cells were positive for CD34, and the diagnosis was SFT originating from the peritoneum.
  • CONCLUSIONS: This case gave us some difficulty, and the correct diagnosis of the peritoneal mass was valuable.
  • To diagnose the malignant potential of this type of tumor accurately may have value to direct the appropriate therapeutic operations after surgery and postoperative progress observation.
  • [MeSH-major] Neoplasms, Fibrous Tissue / diagnosis. Neoplasms, Fibrous Tissue / pathology. Peritoneal Neoplasms / diagnosis. Peritoneal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17006407.001).
  • [ISSN] 1234-1010
  • [Journal-full-title] Medical science monitor : international medical journal of experimental and clinical research
  • [ISO-abbreviation] Med. Sci. Monit.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Antigens, CD34
  •  go-up   go-down


6. Ba-Ssalamah A, Bastati N, Uffmann M, Pretterklieber M, Schima W: [Peritoneum and mesenterium. Radiological anatomy and extent of peritoneal diseases]. Radiologe; 2009 Jun;49(6):543-54; quiz 555-6
MedlinePlus Health Information. consumer health - Peritoneal Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Peritoneum and mesenterium. Radiological anatomy and extent of peritoneal diseases].
  • [Transliterated title] Peritoneum und Mesenterium: Radiologische Anatomie und Ausbreitungswege intraabdomineller Erkrankungen.
  • The abdominal cavity is subdivided into the peritoneal cavity, lined by the parietal peritoneum, and the extraperitoneal space.
  • The visceral peritoneum covers the intraperitoneal organs and part of the pelvic organs.
  • The parietal and visceral layers of the peritoneum are in sliding contact; the potential space between them is called the peritoneal cavity and is a part of the embryologic abdominal cavity or primitive coelomic duct.
  • To understand the complex anatomical construction of the different variants of plicae and recesses of the peritoneum, an appreciation of the embryologic development of the peritoneal cavity is crucial.
  • This knowledge reflects the understanding of the peritoneal anatomy, deep knowledge of which is very important in determining the cause and extent of peritoneal diseases as well as in decision making when choosing the appropriate therapeutic approach, whether surgery, conservative treatment, or interventional radiology.
  • [MeSH-major] Magnetic Resonance Imaging. Mesentery / diagnostic imaging. Mesentery / pathology. Peritoneal Diseases / diagnosis. Peritoneum / diagnostic imaging. Peritoneum / pathology. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiographics. 1995 Jul;15(4):755-70 [7569127.001]
  • [Cites] Radiographics. 2005 Mar-Apr;25(2):351-65 [15798054.001]
  • [Cites] Eur Radiol. 1998;8(6):886-900 [9683690.001]
  • [Cites] Radiographics. 1992 Nov;12 (6):1051-68 [1439011.001]
  • [Cites] Radiographics. 2007 Jan-Feb;27(1):129-43 [17235003.001]
  • [Cites] Radiographics. 2004 Oct;24 Suppl 1:S133-46 [15486237.001]
  • [Cites] Radiology. 1987 Jun;163(3):593-604 [3575702.001]
  • [Cites] J Vasc Surg. 1990 Feb;11(2):326-30 [2299750.001]
  • [Cites] Am J Hum Biol. 1993;5(4):507 [28548406.001]
  • [Cites] Radiology. 1986 May;159(2):311-7 [3515415.001]
  • [Cites] Radiology. 1999 Jun;211(3):737-42 [10352599.001]
  • [Cites] Am Surg. 2002 Sep;68(9):832-5 [12356161.001]
  • [Cites] J Comput Assist Tomogr. 2005 Jul-Aug;29(4):430-7 [16012296.001]
  • [Cites] Radiology. 1983 Oct;149(1):231-9 [6611931.001]
  • [Cites] Radiographics. 1986 Jan;6(1):55-74 [3685484.001]
  • [Cites] J Comput Assist Tomogr. 1995 Nov-Dec;19(6):963-6 [8537534.001]
  • [Cites] Radiology. 1984 Feb;150(2):485-90 [6691106.001]
  • [Cites] Radiographics. 2007 May-Jun;27(3):707-20 [17495288.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1973 Sep;119(1):198-206 [4744725.001]
  • [Cites] AJR Am J Roentgenol. 1985 Mar;144(3):567-75 [3871565.001]
  • (PMID = 19241053.001).
  • [ISSN] 1432-2102
  • [Journal-full-title] Der Radiologe
  • [ISO-abbreviation] Radiologe
  • [Language] ger
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 21
  •  go-up   go-down


7. Hisamatsu E, Takagi S, Nomi M, Sugita Y: A case of bilateral abdominoscrotal hydroceles without communication with the peritoneum. Indian J Urol; 2010 Jan-Mar;26(1):129-30
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of bilateral abdominoscrotal hydroceles without communication with the peritoneum.
  • According to several etiological theories, it is necessary that ASH have communication with the peritoneum.
  • We present a case of bilateral ASH that had no communication with the peritoneum.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Urol. 1988 Apr;61(4):347-9 [3382888.001]
  • [Cites] Urology. 2000 May;55(5):771-3 [10792099.001]
  • [Cites] Eur J Pediatr Surg. 2006 Aug;16(4):282-4 [16981097.001]
  • [Cites] Urology. 2006 Aug;68(2):428.e9-11 [16904478.001]
  • [Cites] J Urol. 2001 Jan;165(1):225-7 [11125413.001]
  • (PMID = 20535302.001).
  • [ISSN] 1998-3824
  • [Journal-full-title] Indian journal of urology : IJU : journal of the Urological Society of India
  • [ISO-abbreviation] Indian J Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2878427
  • [Keywords] NOTNLM ; Abdominoscrotal hydrocele / communication / peritoneum
  •  go-up   go-down


8. Lee BC, Kim KW, Soh KS: Visualizing the network of Bonghan ducts in the omentum and peritoneum by using Trypan blue. J Acupunct Meridian Stud; 2009 Mar;2(1):66-70
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Visualizing the network of Bonghan ducts in the omentum and peritoneum by using Trypan blue.
  • By using it, we observed a weblike network of BHDs which was in various membrane structures, such as the peritoneum, and omenta.
  • [MeSH-major] Coloring Agents / analysis. Meridians. Omentum / chemistry. Peritoneum / chemistry. Trypan Blue / analysis

  • Hazardous Substances Data Bank. Trypan blue .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20633476.001).
  • [ISSN] 2093-8152
  • [Journal-full-title] Journal of acupuncture and meridian studies
  • [ISO-abbreviation] J Acupunct Meridian Stud
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Coloring Agents; I2ZWO3LS3M / Trypan Blue
  •  go-up   go-down


9. Bilgin T, Ozuysal S, Cankiliç H: Primary psammocarcinoma of the peritoneum. Int J Gynecol Cancer; 2006 Jan-Feb;16 Suppl 1:129-31
Hazardous Substances Data Bank. CARBOPLATIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary psammocarcinoma of the peritoneum.
  • Psammocarcinoma is a rare type of serous carcinoma arising from the ovaries or the peritoneum.
  • Primary surgical debulking with complete resection of the tumor should be the main surgical approach, while the benefit of postoperative chemotherapy remains unknown.
  • A new case of primary peritoneal psammocarcinoma with survival after an initial diagnosis of 5.5 years is presented with a literature review.
  • [MeSH-major] Adenocarcinoma / pathology. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Peritoneal Neoplasms / pathology

  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16515580.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] BG3F62OND5 / Carboplatin; P88XT4IS4D / Paclitaxel
  • [Number-of-references] 11
  •  go-up   go-down


10. Karioti A, Hatzoglou C, Zarogiannis S, Deligiorgi T, Kourti P, Giannopoulou M, Arampatzis S, Liakopoulos V, Gourgoulianis K, Molyvdas PA, Stefanidis I: Spironolactone increases permeability of visceral sheep peritoneum. Adv Perit Dial; 2009;25:16-9
Hazardous Substances Data Bank. SPIRONOLACTONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spironolactone increases permeability of visceral sheep peritoneum.
  • The aim of the present study was to investigate by means of Ussing chamber technique the effect of spironolactone on the transmesothelial permeability of visceral sheep peritoneum in vitro.
  • Peritoneal samples from the omentum of adult sheep were collected immediately after slaughter in a cooled and oxygenated Krebs-Ringer bicarbonate (KRB) solution.
  • Isolated intact sheets of peritoneum were mounted in an Ussing-type chamber.
  • Our data clearly show that spironolactone increases the permeability of visceral sheep peritoneum in a lasting manner.
  • Increased peritoneal permeability could result in increased sodium removal, which has acknowledged beneficial effects both in patients undergoing peritoneal dialysis and in patients with heart failure.
  • Further clinical studies investigating the effect of spironolactone on sodium removal in peritoneal dialysis are justified.
  • [MeSH-major] Peritoneum / metabolism. Spironolactone / pharmacology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19886311.001).
  • [ISSN] 1197-8554
  • [Journal-full-title] Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
  • [ISO-abbreviation] Adv Perit Dial
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Mineralocorticoid Receptor Antagonists; 27O7W4T232 / Spironolactone
  •  go-up   go-down


11. Alberti N, Serrano-Egea A, García-García E, Ballestín C, Pérez-Barrios A, López-Ríos F, de Agustín P: Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistry. Acta Cytol; 2007 Mar-Apr;51(2):203-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistry.
  • BACKGROUND: Primary papillary serous carcinoma (PPSC) of the peritoneum is a rare neoplasm, histologically indistinguishable from papillary serous carcinoma of the ovary, which diffusely involves the peritoneum but spares or minimally invades the ovaries.
  • To the best of our knowledge, the preoperative and the fine needle aspiration diagnosis of this disorder have not been reported before.
  • CASE: A woman developed an extensive peritoneal neoplasm 4 years after hysterectomy and bilateral salpingo-oophorectomy for benign disease.
  • Fine needle aspiration of the tumor was performed, and the cytologic and immunocytochemical findings were consistent with papillary serous carcinoma.
  • A diagnosis of PPSC of the peritoneum was rendered because review of all slides from previous surgical specimens showed no evidence of carcinoma and no other primary tumors were found elsewhere.
  • CONCLUSION: Fine needle aspiration cytology coupled with immunocytochemical and clinical data allows an unequivocal preoperative diagnosis of papillary serous carcinoma (primary peritoneal or with an ovarian origin).
  • The sole limitation to establish a primary peritoneal origin before surgery is the requirement to histologically study the ovaries.
  • Based on this fact, the preoperative fine needle aspiration cytology diagnosis of PSCP should be restricted to oophorectomized patients.
  • [MeSH-major] Cystadenocarcinoma, Papillary / diagnosis. Cystadenocarcinoma, Serous / diagnosis. Ovarian Neoplasms / diagnosis. Peritoneal Neoplasms / diagnosis
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Ascites / etiology. Biomarkers, Tumor / analysis. Biomarkers, Tumor / biosynthesis. Biopsy, Fine-Needle / methods. Diagnosis, Differential. Female. Humans. Hysterectomy. Immunohistochemistry / methods. Middle Aged. Pleural Effusion, Malignant / etiology. Pleural Effusion, Malignant / pathology. Predictive Value of Tests. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17425204.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


12. Liang Q, Xu SR, Liu W, Deng LX, Sun DY: [Expressions of aquaporin-1 on peritonea in hepatic cirrhotic rats with ascites]. Zhonghua Yi Xue Za Zhi; 2005 Apr 20;85(15):1027-30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expressions of aquaporin-1 on peritonea in hepatic cirrhotic rats with ascites].
  • OBJECTIVE: To investigate the changes of aquaporin (AQP-1) expressions on peritonea in liver cirrhotic rats with ascites, and to study the correlation between AQP-1 expressions and ascites form.
  • The distribution and protein expressions of AQP-1 on the rats' peritonea were measured with immunohistochemistry assay, and the expressions of APQ-1 mRNA were tested with relative GAPDH quantitative RT-PCR. RESULTS:.
  • (1) The expressions of AQP-1 were mainly on the endothelial cells of capillary vessels and venules on the rats' peritonea, and also on mesothelial cells. (2) There was no statistically significant difference between the expressions of AQP-1 protein and mRNA in the two groups on the early stage of liver cirrhosis. (3) Downregulations of the expressions of AQP-1 protein and mRNA were observed in B group on the advanced cirrhotic stage.
  • CONCLUSION: Expressions of AQP-1 were downregulated on the peritonea of rats with decompensated liver cirrhosis, which may play a role in the formation of ascites.
  • The changes of AQP-1 Expressions on peritoneal mesothelial cells which were fewer than those on the endothelial cells may be few relations to ascites form.
  • [MeSH-major] Aquaporin 1 / biosynthesis. Ascites / metabolism. Liver Cirrhosis, Experimental / metabolism. Peritoneum / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16029543.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / RNA, Messenger; 146410-94-8 / Aquaporin 1
  •  go-up   go-down


13. Gu Y, Zhang X, Kong B, Yu Y: Neovagina constructed with the peritoneum of the anterior abdominal wall. J Obstet Gynaecol Res; 2010 Jun;36(3):651-5
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neovagina constructed with the peritoneum of the anterior abdominal wall.
  • OBJECTIVE: To describe the successful construction of a neovagina with the peritoneum from the anterior abdominal wall for six hypermicrosomic patients diagnosed with Rokitansky syndrome.
  • MATERIAL & METHODS: A neovagina was created using peritoneum from the anterior abdominal wall.
  • CONCLUSIONS: The application of the peritoneum from the anterior abdominal wall for the hypermicrosomic patient diagnosed with Rokitansky syndrome has the advantage of providing sufficient length for the creation of a neovagina.
  • [MeSH-major] Gynecologic Surgical Procedures / methods. Peritoneum / surgery. Reconstructive Surgical Procedures / methods. Vagina / abnormalities. Vagina / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20598051.001).
  • [ISSN] 1447-0756
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


14. Elsayes KM, Staveteig PT, Narra VR, Leyendecker JR, Lewis JS Jr, Brown JJ: MRI of the peritoneum: spectrum of abnormalities. AJR Am J Roentgenol; 2006 May;186(5):1368-79
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MRI of the peritoneum: spectrum of abnormalities.
  • OBJECTIVE: Our objective was to detail peritoneal anatomy, techniques for optimizing peritoneal MRI, and the MRI characteristics of several disease processes that frequently involve the peritoneum.
  • CONCLUSION: Homogeneous fat suppression and dynamic contrast-enhanced imaging, including delayed imaging, are critical technical factors for successful lesion detection and characterization on peritoneal MRI.
  • [MeSH-major] Magnetic Resonance Imaging. Peritoneal Diseases / diagnosis. Peritoneal Neoplasms / diagnosis. Peritoneum / pathology

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Peritoneal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16632733.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 18
  •  go-up   go-down


15. Qin RS, Ma YG, Bi HS, Yang X, Zhang J, Yuan J, Li JN: [Laparoscopically assisted neovaginaplasty using peritoneum as vaginal mucous substitute]. Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Mar;24(2):129-30
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopically assisted neovaginaplasty using peritoneum as vaginal mucous substitute].
  • METHODS: Laparoscopically using peritoneum as neovagina lining.
  • RESULTS: From March 2005 to September 2006, this technique was adopted to treat 10 patients whose diagnosis was congenital absence of vagina.
  • CONCLUSIONS: Laparoscopically assisted neovaginaplasty, in which peritoneum was substituted for vaginal mucous membrane, was a kind of ideal approach of vaginal creation.
  • [MeSH-major] Laparoscopy. Peritoneum / transplantation. Reconstructive Surgical Procedures / methods. Vagina / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18590216.001).
  • [ISSN] 1009-4598
  • [Journal-full-title] Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery
  • [ISO-abbreviation] Zhonghua Zheng Xing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


16. Rose PG, Drake R, Braly PS, Bell MC, Wenham RM, Hines JH, Alvarez-Secord A, Soltes-Rak E, Childs BH, Herzog TJ: Preliminary results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. J Clin Oncol; 2009 May 20;27(15_suppl):5546

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preliminary results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.
  • : 5546 Background: Objectives are to estimate efficacy and safety of a novel taxane/platinum chemotherapy doublet in combination with bevacizumab (B), as first-line treatment of advanced cancer of the ovary, peritoneum or fallopian tube (FT), after initial debulking surgery.
  • 95 (86%) of subjects had completed the chemotherapy cycles with 87 of the 95 having started on the B-only maintenance cycles.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962510.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Dei Tos AP, Rossi S, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Amore P, Casali PG: The natural history of imatinib-naive GIST: A retrospective analysis of 929 cases with long-term follow-up. J Clin Oncol; 2009 May 20;27(15_suppl):10555

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Disease status at diagnosis was localized in 767 and metastatic in 111 cases.
  • 516 cases were gastric, 229 ileal/jejunal, 26 duodenal, 22 colonic, 28 rectal, and 25 peritoneal/retroperitoneal.
  • Metastatic sites included liver (5%), peritoneum (10%), lymph-node (1%), skin and soft tissue (0.5%), and lungs (0.2%).
  • Mitotic activity, tumor size and anatomic site correlated with overall survival at multivariate analysis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963941.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Nakai Y, Isayama H, Sasaki T, Sasahira N, Hirano K, Tsujino T, Tada M, Kawabe T, Omata M: The role of S-1 in gemcitabine-refractory pancreatic cancer: A retrospective single-institution study. J Clin Oncol; 2009 May 20;27(15_suppl):e15648

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were no differences in baseline characteristics at PD for Gem between PreS-1 and PostS-1 Groups, except for metastasis to peritoneum more prevalent in PreS-1 Group (44.7% in PreS-1 Group and 23.0% in PostS-1 Group, p=0.023).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962734.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Di Battista M, Saponara M, Pantaleo MA, Catena F, Santini D, Lolli C, Di Scioscio V, Astorino M, Maleddu A, Nannini M, Biasco G: Microscopic margins of resection in gastrointestinal stromal tumor (GIST): An analysis of 122 patients. J Clin Oncol; 2009 May 20;27(15_suppl):10554

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microscopic margins of resection in gastrointestinal stromal tumor (GIST): An analysis of 122 patients.
  • The prognosis is strongly correlated with both tumor size and mitotic index.
  • The most common sites of tumor origin were the stomach (54.9%) and the small bowel (36.9%).
  • Sites of tumor metastasis were liver (18.2%), peritoneum (36.4%) or both (19.3%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963950.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Picozzi VJ, Canlas LA, Sicuro PL, Malpass TW: A phase II trial of gemcitabine, docetaxel, and bevacizumab (GDB) in metastatic pancreas cancer. J Clin Oncol; 2009 May 20;27(15_suppl):4606

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eligiblity criteria included 1) diagnosis of MPC, 2) chemotherapy naivity, 3) ECOG performance status 0 /1, 4) organ function adequate for therapy.
  • Secondary endpoints included therapy toxicity, radiographic RR (RECIST criteria), tumor marker RR (CA 19.9) and OS.
  • Primary metastatic disease sites were liver (n=18), peritoneum ( n=6), lymph node ( n=2) and lung (n=1).
  • To date, disease control at 8 wks is 100% (24/24 pts) radiographic RR is 48% (12/25 pts) and tumor marker RR is 95% (18/19 evaluable pts expressed CA19.9, median decline 80%, 5 pts normalized) .

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964143.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Kersten S, Wein A, Albrecht H, Reulbach U, Maennlein G, Wolff K, Ostermeier N, Hohenberger W, Hahn EG, Boxberger F: Palliative systemic chemotherapy with gemcitabine (GEM) and 5-fluorouracil (5-FU) as 24h-infusion in patients with advanced inoperable biliary tract cancer (UICC stage IV). J Clin Oncol; 2009 May 20;27(15_suppl):e15633

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e15633 Background: Due to the late diagnosis of biliary tract carcinomas in an advanced tumor stage, the application of palliative chemotherapy frequently remains as a possible treatment option.
  • METHODS: Evaluation of 35 pts. based on our prospective tumor registry data; essential inclusion criteria: histologically proven adeno-carcinoma, UICC stage IV, chemonaivity; all the pts. were presented in the interdisciplinary tumorboard of Erlangen University and were primarily non-curatively-resectable (n = 35); evaluation period: 11/1998 - 09/2008; treatment schedule: 1.000 mg/m<sup>2</sup> of GEM as a 0.5h-infusion (inf.) combined with 2.000 mg/m<sup>2</sup> of 5-FU as a 24h-inf. via port catheter on day 1, 8, 15 qd 22.
  • RESULTS: Median age: 64 years; men/women: n=18/17; ECOG 0/1/2: n=10/21/4; localisation: intrahepatic bile ducts: n=19, extrahepatic bile ducts: n=11; gall bladder: n=4; metastases: liver: 91.4%, lymph nodes: 51.4%, peritoneum: 28.8%, bones: 8.6%, intestine: 8.6%, skin: 2.9%, lungs: 2.9%; chemotherapy applications: total number: 486, average value/patient: 13.9; CA 19-9 elevated yes/no: n=13/22 (37.1%/62.9%); CEA elevated yes/no: n=15/9 (42.9%/25.7%, not evaluable: 11); higher grade toxicity (III or IV): leukocytopenia III: 14.3%, thrombocytopenia III: 2.9%, weariness III: 2.9%, diarrhea III: 5.7%, diarrhea IV: 2.9%, vomiting IV: 2.9%, pain III: 5.7%, ascites III: 5.7%, infections III: 2.9%, thromboembolia IV: 2.9%, elevated bilirubin value III: 1.7%, grade IV: 8.3%; deep leg vein thrombosis: 15%; median TTP: 5.1 months (95% CI: 2.9 - 7.2); median overall survival: 10.4 months (95% CI: 7.9 - 12.9); 6-months-/1-year-/2-year-survival rate: 65.7%/45.7%/17.1%; response rate: PR: n=5 (14.3%), SD: n=18 (51.4%), PD: n=7 (20%), not evaluable: n=5 (14.3%); tumor control (PR/SD): n=23 (65.7%); median follow-up: 10.4 months.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962748.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Spreafico F, Piva L, D'Angelo P, Terenziani M, Collini P, Gandola L, Bianchi M, Tamburini A, Provenzi M, Fossati Bellani F: Are all stage III Wilms tumors the same? Data from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). J Clin Oncol; 2009 May 20;27(15_suppl):10030

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 10030 Background: Criteria to classifying Wilms tumor (WT) as stage III are much heterogeneous, including factors referring both to tumor biology and surgical skills.
  • Reasons for stage III as follows: lymph nodes (LN) 40 cases (alone 28 cases, combined with other factors 12); cava vein tumor thrombus 7, peritoneum involvement 8, post-operative gross or microscopic tumor remains 24, pre-operative rupture 9, surgical rupture 17.
  • Adjuvant therapy consisted of 8-months vincristine/dactinomycin/doxorubicin + flank 1440 cGy RT (whole abdominal 15 Gy in case of diffuse peritoneal contamination).
  • Overall 16 tumor failure occurred (2 in anaplastic tumors): abdominal relapse 8 (combined to other extra-abdominal site 3), lung 5, tumor progression 2, metacronous tumor 1.
  • 1440 cGy flank RT warranted satisfactory local tumor control.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962574.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Cassier PA, Blesius AA, Perol D, Ray-Coquard I, Adenis A, Bui B, Bertucci F, Rios M, Le Cesne A, Blay J: Neoadjuvant imatinib in patients with locally advanced GIST in the prospective BFR14 trial. J Clin Oncol; 2009 May 20;27(15_suppl):10551

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twenty patients were PS 0 or 1, primary tumor sites were: small intestine (n=7), peritoneum (n=7), rectum (n=4), stomach (n=4), esophagus (n=2), and pelvis (n=1).
  • Nine of the 25 patients underwent surgical resection of the primary tumor after a median of 7.3 (range 3.4-12.1) months of treatment with IM.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963947.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Atassi Z, Varga D, Plotzki K, Kurzeder C, Kreienberg R: Peritoneal metastases in breast cancer patients: Differences in survival depending on histological subtype. J Clin Oncol; 2009 May 20;27(15_suppl):e12024

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peritoneal metastases in breast cancer patients: Differences in survival depending on histological subtype.
  • Metastatic involvement of peritoneum and retroperitoneum is unusual and unexpected.
  • The aim of the study was to perform a comprehensive analysis of breast cancer patients with peritoneal metastases and to compare survivals depending on biological subtypes.
  • METHODS: 44 breast cancer pts with peritoneal metastases were detected out of a database of 2,500 breast cancer patients treated in one institution between 1995 and 2005.
  • Median survival calculated from peritoneal metastases in histologic subgroups was as follows: Median progression free survival was 36.5 months for ductal invasive carcinoma, and 23.5 months for lobular invasive breast cancer.
  • CONCLUSIONS: Patients with peritoneal metastases are a heterogenous group with a different outcome.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964300.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Grande C Sr, Quintero G, Mel JR, Huidobro G, Campos B, Candamio S, Méndez JC, Salgado M, Álvarez E, Casal J: Phase II study of biweekly XELOX (capecitabine and oxaliplatin) as first line chemotherapy in elderly patients with metastatic colorectal cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e15053

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Treatment was continued until 12 cycles, tumour progression or innaceptable toxicity.
  • Liver 78.6%, Lung 32.1%, Local tumour 7.1%, Retroperitoneum 14.2%, Peritoneum 10.7%.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964537.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Bertulli R, Fumagalli E, Coco P, Messina A, Morosi C, Dileo P, Casali PG: Unusual metastatic sites in gastrointestinal stromal tumor (GIST). J Clin Oncol; 2009 May 20;27(15_suppl):10566

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual metastatic sites in gastrointestinal stromal tumor (GIST).
  • : 10566 Background: Metastases from GIST usually affect liver and peritoneum.
  • RESULTS: Thirteen pts (5%), M/F:10/3, median age 50 yrs (34-68 y), developed uncommon MS in a median time of 42 months from their primary diagnosis (0-120 m).
  • Nine pts showed bone metastases along with peritoneal and/or hepatic lesions.
  • In the others, imaging and evidence of progression elsewhere were used as clinical criteria for diagnosis of bone metastatization.
  • Nine pts died of disease progression after a median time of 17 months (3-40 m) from bone metastases diagnosis.
  • Last pt died in few months after parotid gland and subcutaneous metastases diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963787.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Power DG, Jhawer M, Feilchenfeldt JW, Kelsen DP, Shah MA: Metastatic gastroesophageal cancer and long-term survival. J Clin Oncol; 2009 May 20;27(15_suppl):4560

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sites of M1 are: peritoneum(35), single visceral organ(19), M1 lymph nodes (24), >1 site (25).
  • Surgery was performed in 28 pts, 26 gastrectomies (15 with occult peritoneal M1, 11 once peritoneal M1 cleared) and 2 metastatectomies; 7 pts received RT(6 to primary, 1 to M1 site).
  • We are now exploring tumor and normal tissue from LTS versus matched controls (survival <1 year) for molecular/genomic correlates for LTS No significant financial relationships to disclose.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963060.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Aprile G, Miscoria M, Baldin P, Casetta A, Pandolfi M, Di Loreto C, Pizzolitto S, Pizzolitto S, Foltran L, Fasola G, Puglisi F: Chemotherapy-induced thymidine phosphorylase modulation in colorectal cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e15050

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sites of biopsied metastases were liver (n=41), lung (n=10), and peritoneum (n=6).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964542.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Palassini E, Stacchiotti S, Collini P, Pilotti S, Pastorino U, Cantù G, Fiore M, Gronchi A, Casali PG: Solitary fibrous tumor: A retrospective analysis on 65 patients from a reference center. J Clin Oncol; 2009 May 20;27(15_suppl):10572

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary fibrous tumor: A retrospective analysis on 65 patients from a reference center.
  • Local recurrence, distant metastases and overall survival were analyzed both from time of diagnosis and from time of local recurrence/distant metastasis.
  • RESULTS: 65 patients were identified (M/F: 33/32 - age: mean 54 yrs, range 19-85 yrs - site: peritoneum 45%, pleura 21%, lower-limb 17%, other 18% - extension at diagnosis: localized 94%, locally-advanced/unresectable 3%, metastatic 3% - size: median 11 cm, range 2-40 cm).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963780.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Joka M, Pietsch K, Paulick S, Issels R, Jauch K, Mayer B: Heterogeneous expression of prognostic and predictive antigens in primary and metastatic gastric cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e22030

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e22030 Background: Metastatic spread of cancer cells is a key event in tumor progression and in determining the prognosis of patients with malignant disease.
  • Further we compared the expression profile of biomarkers, namely EPCAM, CD44s, HLA-ABC and the associated β chain, HLA-DR, ICAM-1, LFA-3 and E-Cadherin in primary gastric tumors (n=94) and their synchronous metastases (regional lymph nodes n=32, liver n=14, peritoneum n=17) using immunoperoxidase staining.
  • E-cadherin and LFA-3 expression were preferentially increased in distant metastases, but not in locally advanced gastric tumors (liver: E-cadherin, p=0.001; liver and peritoneum: LFA-3, p=0.0067).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963146.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Casali PG, Stacchiotti S, Palassini E, Marrari A, Negri T, Morosi C, Messina A, Pastorino U, Gronchi A, Pilotti S: Evaluation of the antitumor activity of sunitinib malate (SM) in solitary fibrous tumor (SFT). J Clin Oncol; 2009 May 20;27(15_suppl):10571

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of the antitumor activity of sunitinib malate (SM) in solitary fibrous tumor (SFT).
  • : 10571 Background: SFT is a rare soft tissue tumor, with an unpredictable metastatic potential.
  • We explored the activity of SM in SFT, given the vascular pattern of this tumor and our preliminary observations about RTK activation (with upregulation of the PDGFR family, VEGFR and EGFR).
  • METHODS: From April 2008, 5 patients with progressive metastatic SFT resistant to conventional chemotherapy (male/female: 3/2 - mean-age: 58 years - PS: 0-3 - site: peritoneum 3, pleura 1, bladder 1) have been treated with continuous-dosing SM 37.5 mg/day, on an individual use basis.
  • RESULTS: Between 3 weeks and 3 months, 4 in 5 patients had a tumor response according to Choi's criteria (all with RECIST stable disease) .

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963778.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Oaknin AM, Romeo M, Pons F, Perez X, Barretina P, Vidal A, Martí L, Barahona M, Germá J, Ponce J: Behavior of borderline ovarian tumours (BOTs): Single institution experience. J Clin Oncol; 2009 May 20;27(15_suppl):e16560

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We identified 6 patients (7.8%) with noninvasive implants involving abdominal peritoneum (1), pelvic peritoneum (1), omentum (2) and both pelvic peritoneum and omentum (2).
  • With a median follow-up of 3.6 years (0-18.4), we observed 5 recurrences (2 in contralateral ovary, 1 ipsilateral, 1 invasive peritoneal implant, and 1 para-aortic node).
  • All were stage I disease at diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961533.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Grimley PM, Matsuno R, Anderson WF: Population profiles of extra-ovarian and ovarian serous adenocarcinomas: Comparisons with grade stratification. J Clin Oncol; 2009 May 20;27(15_suppl):e16506

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e16506 Background: Molecular studies of ovarian serous adenocarcinomas (OSC) have linked distinct patterns of gene expression or mutations to high or low tumor grade.
  • We aimed to determine whether serous adenocarcinomas of the peritoneum (PSC) or fallopian tubes (FSC) comprised grade-related subgroups comparable to OSC.
  • Incidence rates (IR) stratified by grade were compared by year or age of diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27960765.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Szöllósi A, Ferenc C, Pintér T, Erényi A, Nagy A: [Benign cystic mesothelioma, a rare tumor of the peritoneum]. Magy Seb; 2005 Feb;58(1):35-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Benign cystic mesothelioma, a rare tumor of the peritoneum].
  • [Transliterated title] Benignus cisztikus mesothelioma, a peritoneum ritka daganata.
  • Appendicetomy was performed, during the operation multiple cystic lesions were discovered on the right ovary and the peritoneal surface of the mesentery.
  • Final histology revealed benign cystic mesothelioma, which is a rare lesion of the peritoneum, occurring mainly in women in reproductive age.
  • [MeSH-major] Mesothelioma, Cystic. Peritoneal Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16018599.001).
  • [ISSN] 0025-0295
  • [Journal-full-title] Magyar sebészet
  • [ISO-abbreviation] Magy Seb
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Hungary
  •  go-up   go-down


35. Hassan R, Alexander R: Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium. Hematol Oncol Clin North Am; 2005 Dec;19(6):1067-87, vi
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium.
  • Mesotheliomas are tumors that arise from the mesothelial cells of the pleura, peritoneum, pericardium, or tunica vaginalis.
  • The peritoneum is the second most common site of mesothelioma development and accounts for approximately 10% to 20% of all mesotheliomas.
  • [MeSH-minor] Female. Heart Neoplasms / epidemiology. Heart Neoplasms / pathology. Heart Neoplasms / therapy. Humans. Incidence. Male. Peritoneal Neoplasms / epidemiology. Peritoneal Neoplasms / pathology. Peritoneal Neoplasms / therapy. Survival Analysis. Testicular Neoplasms / epidemiology. Testicular Neoplasms / pathology. Testicular Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Mesothelioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16325124.001).
  • [ISSN] 0889-8588
  • [Journal-full-title] Hematology/oncology clinics of North America
  • [ISO-abbreviation] Hematol. Oncol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 105
  •  go-up   go-down


36. Myles A, Yeo YI, Kim M, Cendan J, Kurenov S, Peters J: Interactive peritoneum in a haptic surgery illustration environment. Stud Health Technol Inform; 2009;142:221-3
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interactive peritoneum in a haptic surgery illustration environment.
  • We describe a fully interactive, low-overhead and robust peritoneum representation allowing for probing and cutting.
  • The peritoneum implementation has been tested within a surgical illustration environment.
  • [MeSH-major] Peritoneum / surgery. Surgical Procedures, Operative. Touch. User-Computer Interface

  • MedlinePlus Health Information. consumer health - Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19377154.001).
  • [ISSN] 0926-9630
  • [Journal-full-title] Studies in health technology and informatics
  • [ISO-abbreviation] Stud Health Technol Inform
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / R21 EB005765-01A2
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


37. Lobko PI: [Peritoneum: a new view of the problem]. Morfologiia; 2007;132(4):93-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Peritoneum: a new view of the problem].
  • The author suggests to differentiate the concepts of "location of the organs in regard to the peritoneum" and "coverage of the organs with the peritoneum".
  • According to the author, all the organs, except the ovaries, are located extraperitoneally, but are covered with the peritoneum from one, three or all the sides.
  • [MeSH-major] Organogenesis. Peritoneum / anatomy & histology. Peritoneum / embryology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17969438.001).
  • [ISSN] 1026-3543
  • [Journal-full-title] Morfologii︠a︡ (Saint Petersburg, Russia)
  • [ISO-abbreviation] Morfologiia
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


38. Karioti A, Hatzoglou C, Zarogiannis S, Deligiorgi T, Liakopoulos V, Kourti P, Giannopoulou M, Gourgoulianis K, Molyvdas PA, Stefanidis I: Rapid effect of dexamethasone on the permeability of visceral sheep peritoneum. Adv Perit Dial; 2008;24:2-6
Hazardous Substances Data Bank. MIFEPRISTONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rapid effect of dexamethasone on the permeability of visceral sheep peritoneum.
  • The peritoneal mesothelium is a biologic barrier to water and ion transport.
  • Its functional and structural integrity is crucial for peritoneal dialysis treatment.
  • In vivo studies have shown that corticosteroids increase transcellular water transport and ultrafiltration of the rat peritoneum.
  • In the present study, we used Ussing chamber technique to investigate the effect of dexamethasone on the transmesothelial permeability of the visceral sheep peritoneum in vitro.
  • Peritoneal samples from the omentum of adult sheep were collected in a cooled and oxygenated Krebs-Ringer bicarbonate (KRB) solution immediately after the death of the animals.
  • Our findings clearly indicate that dexamethasone rapidly increases the transmesothelial permeability of visceral sheep peritoneum.
  • [MeSH-major] Dexamethasone / pharmacology. Glucocorticoids / pharmacology. Peritoneum / metabolism

  • MedlinePlus Health Information. consumer health - Steroids.
  • Hazardous Substances Data Bank. DEXAMETHASONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18985993.001).
  • [ISSN] 1197-8554
  • [Journal-full-title] Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
  • [ISO-abbreviation] Adv Perit Dial
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Glucocorticoids; 320T6RNW1F / Mifepristone; 7S5I7G3JQL / Dexamethasone
  •  go-up   go-down


39. Liakopoulos V, Zarogiannis S, Kourti P, Hatzoglou C, Karioti A, Arampatzis S, Giannopoulou M, Musso C, Gourgoulianis K, Molyvdas PA, Stefanidis I: Effect of cimetidine on the electrophysiologic profile of isolated visceral sheep peritoneum. Adv Perit Dial; 2009;25:20-3
Hazardous Substances Data Bank. CIMETIDINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of cimetidine on the electrophysiologic profile of isolated visceral sheep peritoneum.
  • The peritoneal mesothelium is a barrier to ion transport in peritoneal dialysis.
  • Recent reports linked Na+/H+ antiporter stimulation with increasing peritoneal fibroblast proliferation.
  • The aim of the present study was to investigate by means of Ussing chamber experiments the effect of cimetidine on the transmesothelial electrical resistance (R) of isolated visceral sheep peritoneum.
  • Peritoneal samples obtained from adult sheep were collected from the slaughterhouse and transferred in oxygenated Krebs-Ringer bicarbonate (KRB) solution to the laboratory within 30 minutes of the animal's death.
  • The peritoneal tissue was transferred in a cooled KRB solution (4 degrees C, pH 7.5) bubbled with 95% O2/5% CO2.
  • A planar sheet of the visceral peritoneum was mounted in an Ussing-type chamber and cimetidine (10(-3) mol/L) was added to the solution on the apical and basolateral sides.
  • The results of the present study indicate a rapid action of cimetidine on the permeability of visceral sheep peritoneum, probably through inhibition of mesothelial Na+/H+ antiporter.
  • The increase in R observed after addition of the cimetidine clearly indicates the existence of Na+/H+ antiporter on both sides of visceral sheep peritoneum.
  • [MeSH-major] Cimetidine / pharmacology. Histamine H2 Antagonists / pharmacology. Peritoneum / physiology. Sodium-Hydrogen Antiporter / antagonists & inhibitors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19886312.001).
  • [ISSN] 1197-8554
  • [Journal-full-title] Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
  • [ISO-abbreviation] Adv Perit Dial
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Histamine H2 Antagonists; 0 / Sodium-Hydrogen Antiporter; 80061L1WGD / Cimetidine
  •  go-up   go-down


40. Czyzewska K, Grzelak T, Szary B: [Peritoneum as a specific membrane]. Przegl Lek; 2007;64(7-8):489-94

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Peritoneum as a specific membrane].
  • This paper is a review of the literature describing the complexity of the peritoneal membrane structure and functions, mechanisms of the peritoneum failure as a dialyzing membrane and strategies for its protection during prolonged peritoneal dialysis.
  • [MeSH-major] Peritoneal Dialysis. Peritoneum / anatomy & histology. Peritoneum / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18409350.001).
  • [ISSN] 0033-2240
  • [Journal-full-title] Przegla̧d lekarski
  • [ISO-abbreviation] Prz. Lek.
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 68
  •  go-up   go-down


41. Grzelak T, Szary B, Czyzewska K: Hyaluronan influence on diffusive permeability of the peritoneum in vitro. Adv Perit Dial; 2008;24:22-6
Hazardous Substances Data Bank. HYALURONIC ACID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hyaluronan influence on diffusive permeability of the peritoneum in vitro.
  • Hyaluronan (HA), an essential component of peritoneal extracellular matrix, participates in restoring peritoneal integrity and remodeling the peritoneum changed by prolonged peritoneal dialysis and repeated peritonitis episodes.
  • The aim of the present study was to compare urea, creatinine, and uric acid transport across the peritoneal membrane in control conditions and after HA application.
  • Experiments were undertaken using rabbit parietal peritoneum and a modified Ussing-type chamber.
  • Application of HA reduced bi-directional urea transport by a mean of 12%, but did not change the P for creatinine and uric acid.
  • [MeSH-major] Hyaluronic Acid / pharmacology. Peritoneum / metabolism

  • Hazardous Substances Data Bank. UREA .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18985996.001).
  • [ISSN] 1197-8554
  • [Journal-full-title] Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
  • [ISO-abbreviation] Adv Perit Dial
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 268B43MJ25 / Uric Acid; 8W8T17847W / Urea; 9004-61-9 / Hyaluronic Acid; AYI8EX34EU / Creatinine
  •  go-up   go-down


42. Domnina YA, Yeo Y, Tse JY, Bellas E, Kohane DS: Spray-dried lipid-hyaluronan-polymethacrylate microparticles for drug delivery in the peritoneum. J Biomed Mater Res A; 2008 Dec 1;87(3):825-31
Hazardous Substances Data Bank. HYALURONIC ACID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spray-dried lipid-hyaluronan-polymethacrylate microparticles for drug delivery in the peritoneum.
  • Application of controlled release technology to the peritoneum would allow for sustained drug levels.
  • However, some polymeric systems either create adhesions, or rapidly exit the peritoneum; neither result is desirable.
  • Here we have produced particles based on sphyngomyelin, a phospholipid that occurs naturally in the peritoneum, along with hyaluronic acid and the polymethacrylate Eudragit E100 (to modulate drug release).
  • When injected in the murine peritoneum, high SPM particles were disseminated as free particles, without forming collections.
  • These results suggest that microparticulate formulations can be produced that have acceptable drug-releasing properties and are suitable for use in the peritoneum from the standpoint of biocompatibility.
  • [MeSH-major] Acrylates / pharmacokinetics. Drug Carriers. Hyaluronic Acid / pharmacokinetics. Peritoneum / drug effects. Polymers / pharmacokinetics. Polymethacrylic Acids / pharmacokinetics. Sphingomyelins / pharmacokinetics

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2008.
  • (PMID = 18257078.001).
  • [ISSN] 1552-4965
  • [Journal-full-title] Journal of biomedical materials research. Part A
  • [ISO-abbreviation] J Biomed Mater Res A
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / GM073626
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Acrylates; 0 / Albumins; 0 / Biocompatible Materials; 0 / Drug Carriers; 0 / Eudragit E100; 0 / Excipients; 0 / Polymers; 0 / Polymethacrylic Acids; 0 / Sphingomyelins; 25087-26-7 / polymethacrylic acid; 9004-61-9 / Hyaluronic Acid
  •  go-up   go-down


43. Cui J, Xiang J, Huang MJ, Wang L, Huang YH, Wang JP: [Application of GORE-TEX Dual Mesh fixing into peritoneum in sigmoid-colostomy to prevent peristomal hernia]. Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep;12(5):480-2
Hazardous Substances Data Bank. TEFLON .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Application of GORE-TEX Dual Mesh fixing into peritoneum in sigmoid-colostomy to prevent peristomal hernia].
  • OBJECTIVE: To investigate the effect of GORE-TEX Dual Mesh fixing into peritoneum in sigmoid-colostomy on the prevention of peristomal hernia.
  • Patients received papillary sigmoid-colostomy through rectus abdominis and peritoneum in control group and GORE-TEX Dual Mesh fixing into peritoneum during sigmoid-colostomy in observation group.
  • CONCLUSION: GORE-TEX Dual Mesh fixing into peritoneum in sigmoid-colostomy can prevent peristomal hernia.
  • [MeSH-minor] Adult. Aged. Biocompatible Materials. Female. Humans. Male. Middle Aged. Peritoneum / surgery. Polytetrafluoroethylene. Surgical Mesh

  • MedlinePlus Health Information. consumer health - Hernia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19742339.001).
  • [ISSN] 1671-0274
  • [Journal-full-title] Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
  • [ISO-abbreviation] Zhonghua Wei Chang Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Randomized Controlled Trial
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biocompatible Materials; 9002-84-0 / Polytetrafluoroethylene
  •  go-up   go-down


44. Johnson MD, Vito F, Xu H: MUC16 expression and risk of adenocarcinoma metastases to peritoneum, pleura, leptomeninges, and brain. Appl Immunohistochem Mol Morphol; 2010 May;18(3):250-3
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MUC16 expression and risk of adenocarcinoma metastases to peritoneum, pleura, leptomeninges, and brain.
  • Transmembrane MUC16 is thought to facilitate anchoring of metastases to other tissues particularly those expressing mesothelin such as pleura and peritoneum.
  • In this study, we evaluated MUC16 and mesothelin immunoreactivity by immunohistochemistry in 11 adenocarcinomas to the leptomeninges, 24 to mesothelin-negative brain, 8 metastases to mesothelin-expressing peritoneum/pleura, 22 to mesothelin-negative peripheral tissues, and 24 with no metastases.
  • Adenocarcinoma metastases to mesothelin-expressing peritoneum or pleura exhibited extensive MUC16 in 75% of cases.
  • Mesothelin-immunoreactivity was detected in 9% of metastases to the leptomeninges, 17% to the brain, none of the metastases to pleura/peritoneum, 50% of adenocarcinomas with local metastases to lymph nodes, etc, and 33% of adenocarcinomas without metastases.
  • Mesothelin expression was significantly more common in nonmetastatic adenocarcinomas than in metastases to the pleura/peritoneum or leptomeninges.
  • Our findings suggest that adenocarcinomas with MUC16 expression may have an increased risk for metastases to pleura/peritoneum but not the leptomeninges or brain.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):478. Xu, Hoadong [corrected to Xu, Haodong]
  • (PMID = 20090516.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Biomarkers, Tumor; 0 / CA-125 Antigen; 0 / GPI-Linked Proteins; 0 / MUC16 protein, human; 0 / Membrane Glycoproteins; 0 / Membrane Proteins; 0 / mesothelin
  •  go-up   go-down


45. Ruiz-Tovar J, Pérez de Oteyza J, Rojo R, Collado MV, García Villanueva A: Papillary serous carcinoma of peritoneum: presentation of 2 cases. Clin Transl Oncol; 2006 Oct;8(10):758-60
Hazardous Substances Data Bank. CARBOPLATIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary serous carcinoma of peritoneum: presentation of 2 cases.
  • Papillar serous carcinoma of peritoneum (PSPC) is an unfrequent neoplasm, histologically similar to papillar serous carcinoma of ovarium.
  • It presents as peritoneal carcinomatosis without evident tumoral focus.
  • [MeSH-major] Carcinoma, Papillary. Peritoneal Neoplasms

  • Hazardous Substances Data Bank. Topotecan .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hepatogastroenterology. 2002 Jul-Aug;49(46):1027-9 [12143193.001]
  • [Cites] J Surg Oncol. 1998 Jul;68(3):144-8 [9701204.001]
  • [Cites] Cancer. 1990 Sep 15;66(6):1091-4 [2400962.001]
  • [Cites] Eur J Gynaecol Oncol. 2003;24(6):552-6 [14658602.001]
  • [Cites] Am J Obstet Gynecol. 1959 Jan;77(1):197-200 [13606191.001]
  • [Cites] Ann Surg. 1995 Jan;221(1):29-42 [7826158.001]
  • [Cites] AJR Am J Roentgenol. 1998 Sep;171(3):687-9 [9725296.001]
  • [Cites] Australas Radiol. 2004 Sep;48(3):421-5 [15345001.001]
  • [Cites] Abdom Imaging. 2003 Nov-Dec;28(6):815-9 [14753596.001]
  • [Cites] Gynecol Oncol. 1993 Nov;51(2):171-4 [8276289.001]
  • [Cites] Abdom Imaging. 1999 Jan-Feb;24(1):78-81 [9933680.001]
  • (PMID = 17074676.001).
  • [ISSN] 1699-048X
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Antineoplastic Agents, Phytogenic; 7M7YKX2N15 / Topotecan; BG3F62OND5 / Carboplatin; P88XT4IS4D / Paclitaxel; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


46. Layman RE, McNally M, Kilian C, Linn J, Roza A, Johnson CP, Adams MB, Shames BD: Does opening the peritoneum at the time of renal transplanation prevent lymphocele formation? Transplant Proc; 2006 Dec;38(10):3524-6
MedlinePlus Health Information. consumer health - Kidney Transplantation.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does opening the peritoneum at the time of renal transplanation prevent lymphocele formation?
  • Opening the peritoneum at the time of transplantation is one method of decreasing the incidence of lymphocele formation.
  • The purpose of this study was to determine whether creating a peritoneal window at the time of transplantation decreases the incidence of lymphocele formation.
  • Records were reviewed to obtain details regarding opening of the peritoneum at the time of transplant and occurrence of lymphocele.
  • RESULTS: During the initial transplant the peritoneum was opened in 35% of patients.
  • Opening the peritoneum did not decrease the incidence of lymphocele.
  • However, more patients with a closed peritoneum required an intervention for a symptomatic lymphocele.
  • In the 11 patients with an open peritoneum and a fluid collection, only one required an intervention.
  • In patients whose peritoneum was left intact, 24% of fluid collections required intervention.
  • CONCLUSION: Creating a peritoneal window at the time of transplantation did not decrease the overall incidence of postoperative fluid collections.
  • However, forming a peritoneal window at the time of transplantation did decrease the incidence of symptomatic lymphocele.
  • [MeSH-major] Kidney Transplantation / methods. Lymphocele / prevention & control. Peritoneum / surgery. Postoperative Complications / prevention & control

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17175321.001).
  • [ISSN] 0041-1345
  • [Journal-full-title] Transplantation proceedings
  • [ISO-abbreviation] Transplant. Proc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Mourad N, Duvillard P, Sabourin JC: [Borderline serous tumor of the peritoneum: report of two cases]. Ann Pathol; 2007 Jun;27(3):239-342
MedlinePlus Health Information. consumer health - Mesothelioma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Borderline serous tumor of the peritoneum: report of two cases].
  • [Transliterated title] Les tumeurs séreuses à la limite de la malignité du péritoine: à propos de deux cas.
  • We report two cases of peritoneal serous tumor of borderline malignancy, a rare tumor that resembles non invasive peritoneal implants of borderline serous tumor of ovarian origin with absent or minimal surface ovarian involvement.
  • The differential diagnosis includes psammocarcinoma and low grade papillary serous carcinoma of the peritoneum.
  • [MeSH-major] Mesothelioma / pathology. Peritoneal Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17978699.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


48. Yiyang Z, Qunxi C, Weiling W: Closure vs. nonclosure of the peritoneum at cesarean delivery. Int J Gynaecol Obstet; 2006 Aug;94(2):103-7
MedlinePlus Health Information. consumer health - Peritoneal Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Closure vs. nonclosure of the peritoneum at cesarean delivery.
  • OBJECTIVE: To compare the frequency and severity of celiac adhesions following cesarean sections performed with and without closure of the parietal and visceral peritoneum.
  • RESULTS: Nonclosure of the parietal peritoneum at the time of the first cesarean section was associated with significantly more visceral adhesions than closure (16.2% vs. 8.1%; P=0.003), and closure of the visceral peritoneum had a similar effect (16.1% vs. 6.7%; P=0.02).
  • After controlling for confounding variables, it was found that closure of the parietal peritoneum reduced the rate of visceral adhesions 2.7-fold.
  • CONCLUSION: Nonclosure of the peritoneum at primary cesarean section is associated with a significantly increased risk of visceral adhesions.
  • [MeSH-major] Cesarean Section / adverse effects. Peritoneal Diseases / etiology. Peritoneum / surgery

  • MedlinePlus Health Information. consumer health - Cesarean Section.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16784747.001).
  • [ISSN] 0020-7292
  • [Journal-full-title] International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • [ISO-abbreviation] Int J Gynaecol Obstet
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Zhou JH, Sun J, Yang CB, Xie ZW, Shao WQ, Jin HM: Long-term outcomes of transvestibular vaginoplasty with pelvic peritoneum in 182 patients with Rokitansky's syndrome. Fertil Steril; 2010 Nov;94(6):2281-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term outcomes of transvestibular vaginoplasty with pelvic peritoneum in 182 patients with Rokitansky's syndrome.
  • OBJECTIVE: To evaluate the technical feasibility and anatomical and functional outcomes of one-stage transvestibular vaginoplasty with pelvic peritoneum for the patients with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome.
  • INTERVENTION(S): Undergoing transvestibular vaginoplasty with pelvic peritoneum.
  • MAIN OUTCOME MEASURE(S): The perioperative results, complications, and anatomical and functional outcomes of transvestibular vaginoplasty with pelvic peritoneum.
  • CONCLUSION(S): Transvestibular vaginoplasty with pelvic peritoneum is an effective and feasible approach for women with MRKH syndrome.
  • [MeSH-major] Gynecologic Surgical Procedures / methods. Gynecologic Surgical Procedures / rehabilitation. Peritoneum / surgery. Vagina / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20303486.001).
  • [ISSN] 1556-5653
  • [Journal-full-title] Fertility and sterility
  • [ISO-abbreviation] Fertil. Steril.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] Mullerian aplasia
  •  go-up   go-down


50. Cueto-Manzano AM: Rapid solute transport in the peritoneum: physiologic and clinical consequences. Perit Dial Int; 2009 Feb;29 Suppl 2:S90-5
MedlinePlus Health Information. consumer health - Kidney Failure.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rapid solute transport in the peritoneum: physiologic and clinical consequences.
  • This review focuses on the physiologic and clinical consequences of rapid solute transport in the peritoneum.
  • Finally, based on recent advances and clinical studies, some strategies for the treatment of fast peritoneal transport are reviewed.
  • [MeSH-major] Biological Transport, Active / physiology. Dialysis Solutions / pharmacokinetics. Kidney Failure, Chronic / metabolism. Peritoneal Dialysis / mortality. Peritoneum / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19270240.001).
  • [ISSN] 0896-8608
  • [Journal-full-title] Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
  • [ISO-abbreviation] Perit Dial Int
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Dialysis Solutions
  • [Number-of-references] 49
  •  go-up   go-down


51. Aletti GD, Podratz KC, Jones MB, Cliby WA: Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer. J Am Coll Surg; 2006 Oct;203(4):521-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer.
  • BACKGROUND: The peritoneum of the cul-de-sac is frequently affected in advanced ovarian cancer patients.
  • Stripping of the pelvic peritoneum (SoP) combined with rectosigmoidectomy (RS) in patients with confluent tumor are safe techniques that can eradicate macroscopic disease.
  • RESULTS: Two hundred forty-four eligible patients were identified; 209 patients had tumor involving the peritoneum of the cul-de-sac.
  • For this subgroup, those who were managed with stripping of the peritoneum (SoP, n=77) or rectosigmoidectomy (RS, N=57) had improved 5-year overall survivals relative to those who were not (n=75). (SoP=37% versus RS=39% versus neither=6%; p < 0.0001).
  • Tumor resection with en bloc RS may be preferable to allowing microscopic or infiltrative residual tumor.
  • [MeSH-major] Colectomy. Colon, Sigmoid / surgery. Ovarian Neoplasms / mortality. Ovarian Neoplasms / surgery. Peritoneum / surgery. Rectum / surgery

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17000396.001).
  • [ISSN] 1072-7515
  • [Journal-full-title] Journal of the American College of Surgeons
  • [ISO-abbreviation] J. Am. Coll. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


52. Alanbay I, Dede M, Ustün Y, Karaşahin E, Deveci S, Günhan O, Yenen MC: Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature. Arch Gynecol Obstet; 2009 Jun;279(6):931-6
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature.
  • Serous psammocarcinoma (SPC) is a rare variant of ovarian carcinoma or peritoneum that may present with features consistent with malignancy, or tumors of low malignant potential.
  • This is two-case reports of a SPC of the ovary and peritoneum and review of the literature.
  • Histological examination revealed endometrioma and psammocarcinoma of the peritoneum.
  • CT scan showed extensive tumor in the lower abdomen, and free fluid in the abdomen and pelvis which appeared to be an ovarian tumor.
  • She underwent a laparotomy and a right and left ovarian tumor measuring about 20 x 15 and 8 x 8 cm, respectively, were seen.
  • [MeSH-major] Carcinoma / pathology. Ovarian Neoplasms / pathology. Ovary / pathology. Peritoneal Neoplasms / pathology. Peritoneum / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18982336.001).
  • [ISSN] 1432-0711
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 29
  •  go-up   go-down


53. Breborowicz A, Oreopoulos DG: Is normal saline harmful to the peritoneum? Perit Dial Int; 2005 Apr;25 Suppl 4:S67-70
Hazardous Substances Data Bank. SODIUM CHLORIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is normal saline harmful to the peritoneum?
  • BACKGROUND: Normal saline (0.9% NaCl) is used during various abdominal surgical interventions and during peritoneal dialysis to rinse the peritoneal cavity.
  • Although no clear clinical evidence exists for the bioincompatibility of normal saline, various experimental studies have suggested that 0.9% NaCl solution can initiate fibrosis of peritoneum.
  • MATERIAL AND METHODS: We review the data derived from in vitro and in vivo experimental studies demonstrating the cytotoxic effect of 0.9% NaCl and its ability to initiate peritoneal adhesions.
  • RESULTS: Normal saline reduces the viability and fibrinolytic activity of peritoneal mesothelial cells.
  • Use of normal saline to wash the peritoneal cavity during abdominal operations or after chronic peritoneal dialysis is more likely to produce adhesions than is no irrigation at all.
  • Chronic exposure of the peritoneum to normal saline causes overgrowth of the connective tissue and formation of new blood vessels within that tissue.
  • CONCLUSION: Normal saline is a bioincompatible solution that predisposes to the formation of peritoneal adhesions and fibrosis of the peritoneum.
  • A 0.9% NaCl solution should therefore not be used to rinse the peritoneal cavity after interruption of peritoneal dialysis.
  • [MeSH-major] Peritoneum / drug effects. Sodium Chloride / adverse effects
  • [MeSH-minor] Animals. Peritoneal Diseases / chemically induced. Rats. Tissue Adhesions / chemically induced

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16300274.001).
  • [ISSN] 0896-8608
  • [Journal-full-title] Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
  • [ISO-abbreviation] Perit Dial Int
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Canada
  • [Chemical-registry-number] 451W47IQ8X / Sodium Chloride
  • [Number-of-references] 21
  •  go-up   go-down


54. McGee SM, Routh JC, Pereira CW, Gettman MT: Minimal contamination of the human peritoneum after transvesical incision. J Endourol; 2009 Apr;23(4):659-63
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minimal contamination of the human peritoneum after transvesical incision.
  • The need for a clean portal of entry may be important to minimize peritoneal contamination after NOTES.
  • Our study examines the resultant microbial contamination of the human peritoneum after transvesical incision and exposure of the abdomen to bladder contents during robot-assisted laparoscopic prostatectomy (RALP) to better understand the potential for infection in transvesical NOTES.
  • The patient's preoperative urine microscopy values, complete blood cell count, and prostate-specific antigen (PSA) levels were recorded, along with the total length of time the cystotomy was open to the peritoneum.
  • Intraoperative samplings of peritoneal fluid were collected before and after transvesical incision and sent for anaerobic, aerobic and fungal cultures.
  • RESULTS: Patients undergoing RALP had peritoneal exposure after transvesical incision for an average of 118 minutes.
  • Five of 60 (8.3%) patients had evidence of novel aerobic bacterial contamination of the peritoneum after RALP.
  • No patient had a positive anaerobic culture or fungal culture from the peritoneum.
  • Preoperative serum leukocyte and PSA levels were elevated in patients with peritoneal contamination (P < 0.05).
  • Remaining clinicopathologic features, total operative time, or open cystotomy time did not predict peritoneal contamination.
  • CONCLUSION: Prolonged peritoneal exposure to bladder contents demonstrates minimal contamination of the abdominal cavity and is without postoperative infectious significance.
  • Transvesical incision would effectively be a clean portal of entry for NOTES with its low rate of peritoneal contamination.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19335214.001).
  • [ISSN] 1557-900X
  • [Journal-full-title] Journal of endourology
  • [ISO-abbreviation] J. Endourol.
  • [Language] ENG
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Younes M: Frozen section of the gastrointestinal tract, appendix, and peritoneum. Arch Pathol Lab Med; 2005 Dec;129(12):1558-64
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Frozen section of the gastrointestinal tract, appendix, and peritoneum.
  • CONTEXT: Intraoperative consultation is frequently requested by surgeons operating on the gastrointestinal tract, appendix, and peritoneum.
  • In this setting, the pathologist's diagnosis plays a central role in determining whether a resection is needed, and if so, how much to resect and whether it was adequate.
  • OBJECTIVE: To review the intraoperative consultation of the gastrointestinal tract, appendix, and peritoneum.
  • DATA SOURCES: The MEDLINE database was queried for keywords, including gastrointestinal, esophagus, stomach, esophageal, gastric, small intestine, and all other names of the gastrointestinal tract, peritoneum, and appendix in combination with frozen section.
  • Close interaction with the surgeon and knowing what is intended from the frozen section, what will be done following a certain diagnosis, and what is the minimal information needed from the pathologist at the time of frozen section are essential for proper patient management.
  • [MeSH-major] Gastrointestinal Diseases / diagnosis. Gastrointestinal Tract / pathology. Peritoneal Diseases / diagnosis. Peritoneum / pathology
  • [MeSH-minor] Appendicitis / diagnosis. Appendicitis / surgery. Humans. Intraoperative Period. MEDLINE. Peritoneal Neoplasms / diagnosis. Peritoneal Neoplasms / secondary. Referral and Consultation

  • MedlinePlus Health Information. consumer health - Peritoneal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16329728.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 25
  •  go-up   go-down


56. Kohane DS, Tse JY, Yeo Y, Padera R, Shubina M, Langer R: Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J Biomed Mater Res A; 2006 May;77(2):351-61
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
  • Drug delivery to the peritoneum is hampered by rapid clearance, and could be improved by application of controlled release technology.
  • We investigated the suitability for peritoneal use of micro- and nanoparticles of poly(lactic-co-glycolic) acid (PLGA), a biodegradable polymer with generally excellent biocompatibility commonly used for controlled drug release.
  • We injected 90 kDa PLGA microparticles, 5-250 microm in diameter, into the murine peritoneum, in dosages of 10-100 mg (n=3-5 per group).
  • Nanoparticles (265 nm) of 90 kDa PLGA also caused much fewer adhesions (6.3% of animals), possibly because they were cleared from the peritoneum within 2 days, and sequestered in the spleen and liver, where foamy macrophages were noted.
  • [MeSH-major] Biocompatible Materials / metabolism. Drug Carriers. Drug Delivery Systems. Lactic Acid / metabolism. Microspheres. Peritoneum. Polyglycolic Acid / metabolism. Polymers / metabolism

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. LACTIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2006 Wiley Periodicals, Inc.
  • (PMID = 16425240.001).
  • [ISSN] 1549-3296
  • [Journal-full-title] Journal of biomedical materials research. Part A
  • [ISO-abbreviation] J Biomed Mater Res A
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / GM00684
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biocompatible Materials; 0 / Delayed-Action Preparations; 0 / Drug Carriers; 0 / Polymers; 0 / polylactic acid-polyglycolic acid copolymer; 26009-03-0 / Polyglycolic Acid; 33X04XA5AT / Lactic Acid
  •  go-up   go-down


57. Rout UK, Saed GM, Diamond MP: Expression pattern and regulation of genes differ between fibroblasts of adhesion and normal human peritoneum. Reprod Biol Endocrinol; 2005;3:1
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression pattern and regulation of genes differ between fibroblasts of adhesion and normal human peritoneum.
  • BACKGROUND: Injury to the peritoneum during surgery is followed by a healing process that frequently results in the attachment of adjacent organs by a fibrous mass, referred commonly as adhesions.
  • Because injuries to the peritoneum during surgery are inevitable, it is imperative that we understand the mechanisms of adhesion formation to prevent its occurrence.
  • This requires thorough understanding of the molecular sequence that results in the attachment of injured peritoneum and the development of fibrous tissue.
  • Recent data show that fibroblasts from the injured peritoneum may play a critical role in the formation of adhesion tissues.
  • Therefore, identifying changes in gene expression pattern in the peritoneal fibroblasts during the process may provide clues to the mechanisms by which adhesion develop.
  • METHODS: In this study, we compared expression patterns of larger number of genes in the fibroblasts isolated from adhesion and normal human peritoneum using gene filters.
  • RESULTS: Results show that several genes are differentially expressed between fibroblasts of normal and adhesion peritoneum and that the peritoneal fibroblast may acquire a different phenotype during adhesion formation.
  • [MeSH-major] Fibroblasts / metabolism. Gene Expression Regulation. Peritoneal Diseases / genetics. Peritoneum / metabolism

  • MedlinePlus Health Information. consumer health - Peritoneal Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Biol. 1993 Dec;123(6 Pt 2):1899-907 [8276905.001]
  • [Cites] Clin Immunol Immunopathol. 1994 Sep;72(3):283-92 [7914840.001]
  • [Cites] Mol Endocrinol. 1995 Mar;9(3):361-7 [7539889.001]
  • [Cites] J Biol Chem. 1996 Jan 12;271(2):1016-21 [8557625.001]
  • [Cites] Cancer Lett. 2001 Apr 26;165(2):201-9 [11275370.001]
  • [Cites] Fertil Steril. 2001 Apr;75(4):763-8 [11287032.001]
  • [Cites] Int J Biochem Cell Biol. 2001 Jul;33(7):723-34 [11390280.001]
  • [Cites] J Neurochem. 2001 Oct;79(1):192-9 [11595771.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2001 Nov;281(5):L1257-63 [11597918.001]
  • [Cites] J Cell Sci. 2001 Dec;114(Pt 23):4143-51 [11739647.001]
  • [Cites] Hum Reprod. 2002 Jan;17(1):69-75 [11756364.001]
  • [Cites] Acta Medica (Hradec Kralove). 2001;44(3):83-7 [11811081.001]
  • [Cites] Front Biosci. 2002 Apr 1;7:e91-115 [11897550.001]
  • [Cites] J Cell Physiol. 2002 Apr;191(1):42-50 [11920680.001]
  • [Cites] Endocrinology. 2002 Jul;143(7):2693-9 [12072403.001]
  • [Cites] Fertil Steril. 1996 Jul;66(1):140-7 [8752626.001]
  • [Cites] Semin Cancer Biol. 1996 Jun;7(3):155-62 [8773301.001]
  • [Cites] J Biol Chem. 1996 Nov 29;271(48):30322-5 [8939990.001]
  • [Cites] Fertil Steril. 1996 Dec;66(6):904-10 [8941053.001]
  • [Cites] Cell. 1997 Feb 7;88(3):323-31 [9039259.001]
  • [Cites] Fertil Steril. 2003 Jan;79(1):164-8 [12524082.001]
  • [Cites] FASEB J. 2003 Feb;17(2):235-46 [12554702.001]
  • [Cites] Gastroenterology. 2003 Feb;124(2):481-93 [12557153.001]
  • [Cites] J Korean Med Sci. 2003 Apr;18(2):225-30 [12692420.001]
  • [Cites] Biochem J. 2003 May 15;372(Pt 1):203-10 [12614196.001]
  • [Cites] Fertil Steril. 2003 Jun;79(6):1404-8 [12798889.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8276-80 [12815108.001]
  • [Cites] J Cell Physiol. 2003 Sep;196(3):532-40 [12891710.001]
  • [Cites] Int J Biochem Cell Biol. 1997 Jan;29(1):19-30 [9076938.001]
  • [Cites] Exp Cell Res. 1997 Apr 10;232(1):118-26 [9141628.001]
  • [Cites] J Biol Chem. 1997 Jul 4;272(27):17145-53 [9202034.001]
  • [Cites] Fertil Steril. 1998 Mar;69(3):511-6 [9531888.001]
  • [Cites] Brain Res Mol Brain Res. 1998 Jun 15;57(2):221-34 [9675420.001]
  • [Cites] J Mol Biol. 1998 Sep 11;282(1):99-109 [9733643.001]
  • [Cites] J Cutan Med Surg. 1998 Dec;3 Suppl 1:S1-1-5 [10082600.001]
  • [Cites] Lancet. 1999 May 1;353(9163):1476-80 [10232313.001]
  • [Cites] J Natl Cancer Inst. 1999 May 5;91(9):790-6 [10328110.001]
  • [Cites] J Exp Med. 1989 Nov 1;170(5):1595-608 [2509626.001]
  • [Cites] Am J Respir Cell Mol Biol. 1999 Dec;21(6):658-65 [10572062.001]
  • [Cites] Cell Death Differ. 2000 Feb;7(2):166-76 [10713731.001]
  • [Cites] Exp Cell Res. 2000 May 25;257(1):180-9 [10854066.001]
  • [Cites] Am J Reprod Immunol. 2000 May;43(5):285-91 [10872608.001]
  • [Cites] Am J Reprod Immunol. 2000 May;43(5):299-304 [10872610.001]
  • [Cites] Wound Repair Regen. 2000 May-Jun;8(3):216-25 [10886812.001]
  • [Cites] Fertil Steril. 2002 Jul;78(1):137-43 [12095503.001]
  • [Cites] Fertil Steril. 2002 Jul;78(1):144-7 [12095504.001]
  • [Cites] Fertil Steril. 2002 Jul;78(1):154-61 [12095506.001]
  • [Cites] Curr Opin Cell Biol. 2002 Oct;14(5):617-23 [12231358.001]
  • [Cites] J Clin Invest. 2002 Nov;110(9):1349-58 [12417574.001]
  • [Cites] Mol Cell Biol. 2003 Jan;23(1):229-37 [12482976.001]
  • [Cites] Am J Obstet Gynecol. 2002 Dec;187(6):1456-60; discussion 1460-1 [12501046.001]
  • [Cites] Fertil Steril. 2003 Jan;79(1):158-63 [12524081.001]
  • [Cites] Am J Pathol. 2003 Sep;163(3):1033-43 [12937144.001]
  • [Cites] Fertil Steril. 2003 Sep;80(3):612-6 [12969707.001]
  • [Cites] World J Gastroenterol. 2003 Sep;9(9):1900-3 [12970872.001]
  • [Cites] Genes Chromosomes Cancer. 2003 Nov;38(3):265-8 [14506702.001]
  • [Cites] Int J Biol Markers. 2003 Jul-Sep;18(3):162-9 [14535585.001]
  • [Cites] J Cell Biol. 2003 Oct 13;163(1):131-42 [14557252.001]
  • [Cites] Am J Respir Cell Mol Biol. 2003 Nov;29(5):537-44 [12738687.001]
  • [Cites] J Biol Chem. 2004 Jan 16;279(3):2053-62 [14570893.001]
  • [Cites] Eur J Cancer. 2004 Oct;40(15):2324-30 [15454259.001]
  • [Cites] Wound Repair Regen. 2004 Sep-Oct;12(5):557-64 [15453838.001]
  • [Cites] Fertil Steril. 2004 Oct;82 Suppl 3:1188-92 [15474094.001]
  • [Cites] Drug Metab Pharmacokinet. 2004 Aug;19(4):245-63 [15499193.001]
  • [Cites] Int J Cancer. 1986 Jun 15;37(6):857-66 [3519473.001]
  • [Cites] J Cell Biol. 1987 Nov;105(5):2111-21 [2960683.001]
  • [Cites] Eur J Biochem. 1989 Apr 1;180(3):487-502 [2653817.001]
  • [Cites] FASEB J. 1990 Apr 1;4(6):1577-90 [2180767.001]
  • (PMID = 15642115.001).
  • [ISSN] 1477-7827
  • [Journal-full-title] Reproductive biology and endocrinology : RB&E
  • [ISO-abbreviation] Reprod. Biol. Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Complementary; 0 / RNA, Messenger; 0 / TGFB1 protein, human; 0 / Transforming Growth Factor beta; 0 / Transforming Growth Factor beta1
  • [Other-IDs] NLM/ PMC548295
  •  go-up   go-down


58. Hwang JH, Song SH, Kim KA, Shin BK, Lee JK, Lee NW, Lee KW: Primary serous papillary carcinoma of the peritoneum mimicking pelvic actinomycosis: a case report and brief literature review. Eur J Gynaecol Oncol; 2010;31(2):214-6
MedlinePlus Health Information. consumer health - Peritoneal Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary serous papillary carcinoma of the peritoneum mimicking pelvic actinomycosis: a case report and brief literature review.
  • Primary serous papillary carcinoma of the peritoneum is a rare tumor, histologically similar to primary ovarian carcinoma.
  • Pelvic CT and MRI are helpful to diagnose primary carcinoma of the peritoneum.
  • We present a case of primary serous carcinoma of the peritoneum mimicking pelvic actinomycosis in a 59-year-old woman.
  • Exploratory laparotomy was performed to remove the mass and the diagnosis was confirmed by pathology.
  • Histopathology examination revealed peritoneal carcinomatosis and primary serous carcinoma of the peritoneum.
  • Pelvic CT and MRI were limited in their ability to differentiate inflammation, such as actinomycosis, from primary carcinoma of the peritoneum.
  • [MeSH-major] Actinomycosis / diagnosis. Cystadenocarcinoma, Papillary / diagnosis. Cystadenocarcinoma, Serous / diagnosis. Peritoneal Diseases / diagnosis. Peritoneal Neoplasms / diagnosis
  • [MeSH-minor] Chemotherapy, Adjuvant. Diagnosis, Differential. Female. Humans. Hysterectomy. Middle Aged

  • Genetic Alliance. consumer health - Anaerobic Actinomyces Infection.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20527245.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


59. Dirican A, Unal B, Ozgor D, Piskin T, Aydin C, Sumer F, Kayaalp C: Perforated hepatic hydatid cyst into the peritoneum with mild symptoms. Case Rep Gastroenterol; 2008 Sep;2(3):439-43

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Perforated hepatic hydatid cyst into the peritoneum with mild symptoms.
  • We present herein a case with mild abdominal symptoms due to hydatid cyst rupture into the peritoneum after trauma.
  • Ultrasonography and computed tomography showed cystic lesions in the liver and peritoneum with intraabdominal free fluid.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg. 2007 Sep;194(3):313-6 [17693274.001]
  • [Cites] World J Surg. 2007 Jun;31(6):1284-91 [17464537.001]
  • [Cites] World J Gastroenterol. 2007 Feb 7;13(5):806-8 [17278209.001]
  • [Cites] Arch Surg. 1980 Jul;115(7):847-50 [7387376.001]
  • [Cites] World J Surg. 2006 Sep;30(9):1722-8 [16807665.001]
  • [Cites] World J Surg. 2006 Oct;30(10):1879-83; discussion 1884-5 [16847712.001]
  • [Cites] World J Surg. 2004 Aug;28(8):731-6 [15457348.001]
  • [Cites] Clin Microbiol Rev. 2004 Jan;17(1):107-35 [14726458.001]
  • [Cites] J Gastrointest Surg. 2003 Jul-Aug;7(5):635-41 [12850676.001]
  • (PMID = 21897796.001).
  • [ISSN] 1662-0631
  • [Journal-full-title] Case reports in gastroenterology
  • [ISO-abbreviation] Case Rep Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Other-IDs] NLM/ PMC3166808
  • [Keywords] NOTNLM ; Hydatid disease / Liver / Rupture / Trauma
  •  go-up   go-down


60. Kourti P, Zarogiannis S, Liakopoulos V, Hatzoglou C, Giannopoulou M, Chronopoulou I, Mertens PR, Potamianos S, Gourgoulianis K, Molyvdas PA, Stefanidis I: Effect of endothelin-1 on the transmesothelial resistance of isolated visceral sheep peritoneum. Adv Perit Dial; 2007;23:38-42

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of endothelin-1 on the transmesothelial resistance of isolated visceral sheep peritoneum.
  • The mesothelium is part of the peritoneal barrier that manages the water and ion transport essential for peritoneal dialysis (PD) treatment.
  • In addition, it has a central role in the pathogenesis of peritoneal fibrosis and the resulting ultrafiltration failure observed in many PD patients.
  • The aim of the present study was to investigate, by means of Ussing chamber experiments, the effect of ET-1 on the transmesothelial electrical resistance (RTM) of isolated visceral sheep peritoneum.
  • Intact sheets of visceral sheep peritoneum were obtained from 12 adult sheep.
  • These results clearly indicate an inhibitory effect of ET-1 on the ionic permeability of visceral sheep peritoneum.
  • The rapid increase in RTM observed after the addition of ET-1 suggests the existence of endothelin receptors (ET-A or ET-B, or both) on visceral sheep peritoneum.
  • [MeSH-major] Endothelin-1 / pharmacology. Peritoneum / physiology
  • [MeSH-minor] Animals. Electric Impedance. Epithelial Sodium Channels / drug effects. Female. In Vitro Techniques. Male. Peritoneal Dialysis. Permeability. Sheep, Domestic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17886600.001).
  • [ISSN] 1197-8554
  • [Journal-full-title] Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
  • [ISO-abbreviation] Adv Perit Dial
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Endothelin-1; 0 / Epithelial Sodium Channels
  •  go-up   go-down


61. van der Wal JB, Jeekel J: Biology of the peritoneum in normal homeostasis and after surgical trauma. Colorectal Dis; 2007 Oct;9 Suppl 2:9-13
MedlinePlus Health Information. consumer health - After Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biology of the peritoneum in normal homeostasis and after surgical trauma.
  • The peritoneum is a serous membrane, which has a protective function for the contents of the abdominal cavity.
  • It maintains homeostasis by allowing exchange of molecules and production of peritoneal fluid, thus providing an environment in which intra-abdominal organs can function properly.
  • When traumatized, whether by surgery or due to inflammatory processes, a series of responses come into action to regenerate the injured part of the peritoneum.
  • One should realize this when performing intra-abdominal surgery, which is in fact operating inside the peritoneal organ.
  • [MeSH-major] Peritoneum / physiology. Peritoneum / surgery. Postoperative Complications / physiopathology. Tissue Adhesions / physiopathology

  • MedlinePlus Health Information. consumer health - Adhesions.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17824965.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Fibrin Fibrinogen Degradation Products; 9001-31-4 / Fibrin; EC 3.4.21.68 / Tissue Plasminogen Activator
  • [Number-of-references] 30
  •  go-up   go-down


62. Demirel Y, Gursoy S, Duran B, Erden O, Cetin M, Balta O, Cetin A: Closure or nonclosure of the peritoneum at gynecological operations. Effect on postoperative pain. Saudi Med J; 2005 Jun;26(6):964-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Closure or nonclosure of the peritoneum at gynecological operations. Effect on postoperative pain.
  • OBJECTIVE: To compare the analgesic requirement and pain scores in the postoperative period between closure and nonclosure of the peritoneum in women undergoing gynecological abdominal surgery.
  • We recommend non-closure of peritoneum at abdominal gynecologic procedure as the method of choice.
  • [MeSH-major] Gynecologic Surgical Procedures. Laparotomy. Pain, Postoperative / prevention & control. Peritoneum / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15983684.001).
  • [ISSN] 0379-5284
  • [Journal-full-title] Saudi medical journal
  • [ISO-abbreviation] Saudi Med J
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] Saudi Arabia
  •  go-up   go-down


63. Goodman MT, Shvetsov YB: Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact? Int J Cancer; 2009 May 1;124(9):2231-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact?
  • Papillary serous carcinoma of the peritoneum (PSCP) has been recognized for almost 5 decades, but little is known about the etiology or pathogenesis of this uncommon malignancy.
  • Although the reason for this temporal trend is unknown, some of the increase may be attributable to reclassification of ovarian carcinoma to the peritoneum.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • [Cites] Gynecol Oncol. 2007 Jun;105(3):762-8 [17383715.001]
  • [Cites] Am J Surg Pathol. 2007 Feb;31(2):161-9 [17255760.001]
  • [Cites] Biometrics. 2006 Sep;62(3):847-54 [16984328.001]
  • [Cites] Am J Surg Pathol. 2006 Feb;30(2):230-6 [16434898.001]
  • [Cites] Am J Obstet Gynecol. 1959 Jan;77(1):197-200 [13606191.001]
  • [Cites] Obstet Gynecol. 1998 Oct;92(4 Pt 1):596-600 [9764635.001]
  • [Cites] J Natl Cancer Inst. 1998 Jun 3;90(11):841-5 [9625172.001]
  • [Cites] Obstet Gynecol. 1998 Feb;91(2):254-9 [9469285.001]
  • [Cites] Stat Med. 1997 Apr 15;16(7):791-801 [9131766.001]
  • [Cites] Cancer Res. 1995 Feb 1;55(3):490-2 [7834614.001]
  • [Cites] Gynecol Oncol. 1993 Nov;51(2):171-4 [8276289.001]
  • [Cites] Gynecol Oncol. 1993 Sep;50(3):347-51 [8406199.001]
  • [Cites] Obstet Gynecol. 1990 Jan;75(1):89-95 [2296429.001]
  • [Cites] Cancer. 1989 Jul 1;64(1):110-5 [2731107.001]
  • [Cites] Am J Obstet Gynecol. 2004 Apr;190(4):1039-45 [15118638.001]
  • [Cites] Int J Gynecol Cancer. 2003 Nov-Dec;13(6):749-55 [14675310.001]
  • [Cites] Cancer. 2003 May 15;97(10 Suppl):2676-85 [12733132.001]
  • [Cites] Cancer. 2003 May 15;97(10 Suppl):2648-59 [12733130.001]
  • [Cites] Cancer. 2003 May 15;97(10 Suppl):2643-7 [12733129.001]
  • [Cites] Gynecol Oncol. 2003 Apr;89(1):148-54 [12694669.001]
  • [Cites] Gynecol Oncol. 2003 Jan;88(1):58-61 [12504628.001]
  • [Cites] Int J Gynecol Cancer. 2001 Sep-Oct;11(5):403-8 [11737473.001]
  • [Cites] Am J Clin Pathol. 2000 Jul;114(1):93-9 [10884804.001]
  • [Cites] Histopathology. 2008 Aug;53(2):127-38 [18298580.001]
  • [Cites] Int J Gynecol Pathol. 2008 Apr;27(2):151-60 [18317228.001]
  • (PMID = 19127596.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / PC / N01-PC-35137; United States / NCI NIH HHS / PC / N01 PC035137; United States / NCI NIH HHS / PC / N02-PC-44401; United States / NCI NIH HHS / CA / N01PC35137; None / None / / N01 PC035137
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS98734; NLM/ PMC2723055
  •  go-up   go-down


64. Tosun M, Samli H, Arikan Y, Solak M, Sahin A, Söylemez Z, Kalkan S: The effects of CO2 pneumoperitoneum on the apoptotic index in the peritoneum. Adv Ther; 2007 Jul-Aug;24(4):883-9
Hazardous Substances Data Bank. Carbon dioxide .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effects of CO2 pneumoperitoneum on the apoptotic index in the peritoneum.
  • This study was undertaken to evaluate the effects of different pressures of CO(2) on the apoptotic index in the peritoneum during laparoscopic surgery.
  • After 60 min, the rats were killed; peritoneum was harvested from the abdominal wall and was cultured in the cell culture laboratory.
  • [MeSH-major] Apoptosis. Carbon Dioxide / adverse effects. Laparoscopy / adverse effects. Peritoneum / pathology. Pneumoperitoneum / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17901037.001).
  • [ISSN] 0741-238X
  • [Journal-full-title] Advances in therapy
  • [ISO-abbreviation] Adv Ther
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 142M471B3J / Carbon Dioxide
  •  go-up   go-down


65. Oğuzkurt P, Kayaselçuk F, Tuncer I, Alkan M, Hiçsönmez A: Evaluation of extracellular matrix protein composition in sacs associated with undescended testis, hydrocele, inguinal hernia, and peritoneum. Urology; 2007 Aug;70(2):346-50

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of extracellular matrix protein composition in sacs associated with undescended testis, hydrocele, inguinal hernia, and peritoneum.
  • OBJECTIVES: To investigate and compare the distribution and intensity of staining of extracellular matrix proteins--laminin, fibronectin, and types 1 and 4 collagen--in various congenital inguinoscrotal abnormalities and the peritoneum through immunohistochemical staining.
  • METHODS: The sacs associated with undescended testis (n = 28), hydrocele (n = 29), inguinal hernia (n = 31), and parietal peritoneum (n = 28) were stained with antibodies for laminin, fibronectin, and types 1 and 4 collagen.
  • The peritoneum served as the control group.
  • RESULTS: The expression of laminin was significantly greater in the sacs associated with undescended testes and inguinal hernia than in the peritoneum.
  • The expression pattern of fibronectin did not differ in the sacs of the different inguinoscrotal abnormalities compared with peritoneum.
  • Type 1 collagen was strongly expressed in the sacs obtained from the hydroceles compared with the other groups and the peritoneum.
  • Expression of type 4 collagen was significantly increased in the sacs associated with hydrocele and inguinal hernia compared with the peritoneum.
  • CONCLUSIONS: The distribution and expression of laminin and types 1 and 4 collagen showed variability in the sacs associated with undescended testis, hydrocele, and inguinal hernia and the peritoneum.
  • The tensile forces that the sacs associated with childhood inguinoscrotal abnormalities are exposed to per se could account for some of the differences seen between the inguinoscrotal tissues and anterior peritoneum.
  • [MeSH-major] Collagen Type I / analysis. Collagen Type I / biosynthesis. Collagen Type IV / analysis. Collagen Type IV / biosynthesis. Cryptorchidism / metabolism. Fibronectins / analysis. Fibronectins / biosynthesis. Hernia, Inguinal / metabolism. Laminin / analysis. Laminin / biosynthesis. Peritoneum / chemistry. Testicular Hydrocele / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17826504.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Collagen Type I; 0 / Collagen Type IV; 0 / Fibronectins; 0 / Laminin
  •  go-up   go-down


66. Schmeler KM, Sun CC, Bodurka DC, Deavers MT, Malpica A, Coleman RL, Ramirez PT, Gershenson DM: Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol; 2008 Mar;108(3):510-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
  • OBJECTIVE: To evaluate the response of women with low-grade serous carcinoma of the ovary or peritoneum to platinum-based neoadjuvant chemotherapy.
  • METHODS: Using institutional databases, we identified 25 women with advanced low-grade serous carcinoma of the ovary or peritoneum treated with neoadjuvant platinum-based chemotherapy between 1989 and 2006.
  • RESULTS: Median patient age at diagnosis was 45 years (range 29-81).
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cystadenocarcinoma, Serous / drug therapy. Ovarian Neoplasms / drug therapy. Peritoneal Neoplasms / drug therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Databases, Factual. Disease-Free Survival. Drug Administration Schedule. Female. Humans. Medical Records. Middle Aged. Neoadjuvant Therapy. Neoplasm Staging. Retrospective Studies. Survival Analysis. Texas. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18155273.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


67. Vansovych VIe, Nychytaĭlo MIu: [The state of natural resistance of organism in patients of different age with adhesive illness of peritoneum]. Klin Khir; 2007 Sep;(9):5-7
MedlinePlus Health Information. consumer health - Seniors' Health.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The state of natural resistance of organism in patients of different age with adhesive illness of peritoneum].
  • The state of natural resistance of organism according to the indices of thiol-disulphid system in patients of various age, suffering the adhesive illness of peritoneum, and the donors was studied up.

  • MedlinePlus Health Information. consumer health - Peritoneal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18320641.001).
  • [ISSN] 0023-2130
  • [Journal-full-title] Klinichna khirurhiia
  • [ISO-abbreviation] Klin Khir
  • [Language] UKR
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Ukraine
  • [Chemical-registry-number] 0 / Sulfhydryl Compounds
  •  go-up   go-down


68. Barbosa CP, Souza AM, Bianco B, Christofolini D, Bach FA, Lima GR: Frequency of endometriotic lesions in peritoneum samples from asymptomatic fertile women and correlation with CA125 values. Sao Paulo Med J; 2009 Nov;127(6):342-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Frequency of endometriotic lesions in peritoneum samples from asymptomatic fertile women and correlation with CA125 values.
  • This study aimed to determine the frequency of endometriosis and the correlation between serum CA125 levels and the presence of endometriotic lesions in the peritoneum of asymptomatic fertile patients.
  • Blood and peritoneum samples were collected.
  • CA125 levels were measured from blood samples, and peritoneum biopsies were studied using histopathological tests.
  • RESULTS: Histopathological evaluation of the peritoneum revealed that 16.25% of the patients had minimal or mild endometriosis.
  • CONCLUSION: The presence of endometriotic lesions in the peritoneum of fertile patients supports the hypothesis that incidental findings of minimal or mild endometriosis may not be of clinical significance, and that the progression of the disease probably occurs as a result of immunological and genetic abnormalities.
  • [MeSH-major] CA-125 Antigen / blood. Endometriosis / blood. Fertility / physiology. Peritoneal Diseases / diagnosis

  • MedlinePlus Health Information. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Peritoneal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20512287.001).
  • [ISSN] 1806-9460
  • [Journal-full-title] São Paulo medical journal = Revista paulista de medicina
  • [ISO-abbreviation] Sao Paulo Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Biomarkers; 0 / CA-125 Antigen
  •  go-up   go-down


69. Lopes JV, Oliveira PG, Sousa JB, Báo SN, Takano GH, Leal II: Histopathologic evaluation of the peritoneum exposed to heat shock: experimental study in rats. Acta Cir Bras; 2007 Sep-Oct;22(5):342-50
Hazardous Substances Data Bank. SODIUM CHLORIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histopathologic evaluation of the peritoneum exposed to heat shock: experimental study in rats.
  • PURPOSE: To evaluate histopathologic alterations of the peritoneum exposed to heat shock.
  • The peritoneal cavity of animals from groups HS, HT, BT and TZ was irrigated with NaCl solution 0.9% at temperatures 50 degrees C, 0 degrees C, 50 degrees C, 37 degrees C and 0 degrees C, respectively.
  • Twenty-four hours later, biopsies of the peritoneum for exams under light and electronic microscopy were performed.
  • The mean peritoneal thickness ranged from 42.26 microm (TZ) to 26.42 microm (CG).
  • CONCLUSION: The heat shock caused no deaths, but promoted significant peritoneal edema without affecting the other histopathologic indicatives.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17923953.001).
  • [ISSN] 0102-8650
  • [Journal-full-title] Acta cirurgica brasileira
  • [ISO-abbreviation] Acta Cir Bras
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 451W47IQ8X / Sodium Chloride
  •  go-up   go-down


70. Lambertucci JR, Villamil QT, Savi D, Dias IC: Genital schistosomiasis mansoni: tubal tumor and parietal peritoneum involvement diagnosed during laparoscopy. Rev Soc Bras Med Trop; 2009 Sep-Oct;42(5):583-6
Genetic Alliance. consumer health - Schistosomiasis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genital schistosomiasis mansoni: tubal tumor and parietal peritoneum involvement diagnosed during laparoscopy.
  • Here, we describe the case of a 31-year-old woman with lower abdominal pain who was diagnosed as presenting a fallopian tube tumor caused by Manson's schistosomiasis.
  • The diagnosis was delayed because her symptoms were considered nonspecific.
  • Involvement of the parietal peritoneum of the ovarian fossa was observed during laparoscopy and confirmed by histological analysis.
  • The left tube and the tumor were excised and schistosomiasis was treated with praziquantel.
  • [MeSH-major] Fallopian Tube Diseases / parasitology. Schistosoma mansoni / isolation & purification. Schistosomiasis mansoni / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19967244.001).
  • [ISSN] 1678-9849
  • [Journal-full-title] Revista da Sociedade Brasileira de Medicina Tropical
  • [ISO-abbreviation] Rev. Soc. Bras. Med. Trop.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Anthelmintics; 6490C9U457 / Praziquantel
  •  go-up   go-down


71. Porjazova E, Zaprjanov Z, Batashki I, Milchev N, Markova D: [Differential diagnostic importance of immunochistochemistry applied at metastases of adenocarcinomas of the peritoneum]. Akush Ginekol (Sofiia); 2009;48(5):20-2
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Differential diagnostic importance of immunochistochemistry applied at metastases of adenocarcinomas of the peritoneum].
  • Patients with metastatic carcinomas with unclear primary tumor site are often clinical and pathological problem.
  • The most frequent reason for peritoneal carcinomas at women is the ovarian cancer.
  • We present the use of four antibodies--Cytokeratin 7 and 20, Beta cathenin and CDX2 and define their positiveness at metastases from different groups of adenocarcinomas in the peritoneum.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / secondary. Colorectal Neoplasms / diagnosis. Colorectal Neoplasms / pathology. Ovarian Neoplasms / diagnosis. Ovarian Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Female. Gene Expression Regulation, Neoplastic. Homeodomain Proteins / genetics. Homeodomain Proteins / metabolism. Humans. Immunohistochemistry. Keratin-20 / genetics. Keratin-20 / metabolism. Keratin-7 / genetics. Keratin-7 / metabolism. Male. Peritoneum / pathology. beta Catenin / genetics. beta Catenin / metabolism

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20198793.001).
  • [ISSN] 0324-0959
  • [Journal-full-title] Akusherstvo i ginekologii︠a︡
  • [ISO-abbreviation] Akush Ginekol (Sofiia)
  • [Language] bul
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bulgaria
  • [Chemical-registry-number] 0 / CDX2 protein, human; 0 / Homeodomain Proteins; 0 / Keratin-20; 0 / Keratin-7; 0 / beta Catenin
  •  go-up   go-down


72. Parakh RS, Zawar MP, Gadgil PA, Kaujalagi NS: Dedifferentiated liposarcoma of the retro-peritoneum: histologically low-grade type. Indian J Pathol Microbiol; 2010 Apr-Jun;53(2):353-5
Genetic Alliance. consumer health - Liposarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dedifferentiated liposarcoma of the retro-peritoneum: histologically low-grade type.
  • A dedifferentiated liposarcoma of the retro-peritoneum of a 45-year-old female is described in this case report.
  • The mass showed a dedifferentiated focus different in color from the surrounding tumor and containing areas of necrosis and hemorrhage.
  • The sections from the dedifferentiated part of the tumor appeared predominantly as benign spindle cell component on histology but the tumor was infiltrating into the kidney.
  • Hence, a close and long-term follow-up is expected in such cases though they look benign.
  • In the retro-peritoneum, a lipoma-like well-differentiated liposarcoma with spindle cell component, like the present tumor, which shows dedifferentiation, should not be overlooked.
  • [MeSH-major] Liposarcoma / diagnosis. Liposarcoma / pathology. Peritoneal Neoplasms / diagnosis. Peritoneal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20551557.001).
  • [ISSN] 0974-5130
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


73. Terada T, Kawaguchi M: Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med; 2005 Jul;206(3):271-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary clear cell adenocarcinoma of the peritoneum.
  • We report on a very rare case of peritoneal clear cell adenocarcinomas.
  • No clear cell adenocarcinoma elements were noted in this tumor.
  • Two peritoneal cystic tumors were detected by imaging modalities around the stomach and spleen, 15 months and 21 months after the follow-up period of the endometrial carcinoma, respectively.
  • The morphologies and immunohistochemical findings of the two peritoneal clear cell adenocarcinomas were different from those of endometrial carcinoma.
  • We believe that the two clear cell adenocarcinomas are not metastatic lesions from the endometrial carcinoma of the uterus, and that they are primary clear cell adenocarcinomas of the peritoneum.
  • [MeSH-major] Adenocarcinoma, Clear Cell / diagnosis. Peritoneal Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15942157.001).
  • [ISSN] 0040-8727
  • [Journal-full-title] The Tohoku journal of experimental medicine
  • [ISO-abbreviation] Tohoku J. Exp. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


74. Freedman RS, Wang E, Voiculescu S, Patenia R, Bassett RL Jr, Deavers M, Marincola FM, Yang P, Newman RA: Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer. Clin Cancer Res; 2007 Oct 1;13(19):5736-44
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer.
  • EXPERIMENTAL DESIGN: We first employed electrospray tandem mass spectrometry to determine tissue-specific concentrations of the eicosanoids prostaglandin E2 (PGE2), the hydroxyeicosatetraenoic acids (12-HETE and 5-HETE), and leukotriene (LTB4), selected for tumor growth potential, and two other bioactive lipids (15-HETE and 13-HODE) with tumor cell proliferation interference potential.
  • Tissues used included EOC tumor, tumor-free malignant peritoneum (MP), and benign peritoneum (BP) from patients with benign pelvic disease.
  • RESULTS: (a) Eicosanoid products were detected in tumor, MP, and BP specimens.
  • Neither 15-HETE nor 13-HODE showed a significant opposite trend toward levels found in BP. (b) Tissue specimens representing common EOC histotypes showed strong coexpressions of cyclooxygenases (COX-1) and prostaglandin E synthases (PGES-1) on tumor cells, whereas intratumoral or peritumoral MO/MA coexpressed COX-1 and COX-2 and PGES-1 and PGES-2, respectively. (c) cDNA microarray analysis of MP, BP, and tumor showed that a number of eicosanoid and arachidonic acid pathway genes were differentially expressed in MP and BP compared with tumor, except for CYP2J2, which was increased in tumors.
  • CONCLUSIONS: Elevated levels of eicosanoid metabolites in tumors and differential expression of eicosanoid and arachidonic acid pathway genes in the peritoneum support the involvement of bioactive lipids in the inflammatory tumor environment of EOC.
  • [MeSH-major] Eicosanoids / metabolism. Gene Expression Regulation, Neoplastic. Ovarian Neoplasms / metabolism. Ovarian Neoplasms / pathology. Peritoneum / metabolism

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17908963.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD163 antigen; 0 / Eicosanoids; 0 / Lipids; 0 / Receptors, Cell Surface; 27YG812J1I / Arachidonic Acid; K7Q1JQR04M / Dinoprostone
  •  go-up   go-down


75. Xiang GA, Chen KY, Wang HN, Xiao FL: [Laparoscopic placement of total peritoneum intraperitoneal onlay mesh in patients with inguinal hernia]. Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar;29(3):504-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopic placement of total peritoneum intraperitoneal onlay mesh in patients with inguinal hernia].
  • OBJECTIVE: To study the efficacy of laparoscopic placement of total peritoneum intraperitoneal onlay mesh (TPIPOM) for treatment of inguinal hernia.
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Peritoneum / surgery. Reconstructive Surgical Procedures / methods. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19304537.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


76. Bhasin RR, Chen MK, Pincus DW: Salvaging the "lost peritoneum" after ventriculoatrial shunt failures. Childs Nerv Syst; 2007 May;23(5):483-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salvaging the "lost peritoneum" after ventriculoatrial shunt failures.
  • CONCLUSION: Because of the benefits of VP over VA shunting, every effort should be made to preserve the peritoneum as the target for the distal catheter.
  • Laparotomy/laparoscopy is useful in locating suitable peritoneal targets when converting to VP shunt after VA shunt failure, or as a final effort before VA shunt conversion.
  • [MeSH-major] Peritoneal Cavity / physiology. Ventriculoperitoneal Shunt / adverse effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Neurochir (Wien). 2005 Mar;147(3):335-8; discussion 338 [15931467.001]
  • [Cites] J Pediatr Surg. 1978 Jun;13(3):247-53 [149845.001]
  • [Cites] J Comput Assist Tomogr. 1978 Jan;2(1):88-91 [670477.001]
  • [Cites] Pediatr Neurosurg. 2002 Mar;36(3):167 [11919455.001]
  • [Cites] Childs Nerv Syst. 1990 Sep;6(6):346-9 [2257549.001]
  • [Cites] Eur J Pediatr Surg. 1995 Aug;5(4):195-7 [7577854.001]
  • [Cites] Can J Surg. 1990 Feb;33(1):37-40 [2302597.001]
  • [Cites] Clin Neurol Neurosurg. 2001 Dec;103(4):245-6 [11714572.001]
  • [Cites] Neurosurgery. 1981 Apr;8(4):469-72 [7242901.001]
  • [Cites] Br J Surg. 1971 May;58(5):372-7 [4930143.001]
  • [Cites] An Esp Pediatr. 1989 Jan;30(1):8-10 [2930090.001]
  • [Cites] J Med Assoc Thai. 1971 May;54(5):361-7 [5580063.001]
  • [Cites] Lancet. 2001 Nov 10;358(9293):1608 [11716888.001]
  • [Cites] Aust Paediatr J. 1984 Mar;20(1):73-4 [6466221.001]
  • [Cites] Surg Neurol. 1984 Nov;22(5):444-8 [6495151.001]
  • [Cites] Childs Nerv Syst. 1991 Aug;7(4):215-7 [1933918.001]
  • [Cites] Ulus Travma Acil Cerrahi Derg. 2003 Apr;9(2):137-9 [12836112.001]
  • [Cites] J Neurosurg. 1966 Jan;24(1):34-42 [5948233.001]
  • [Cites] Surg Neurol. 1979 Jun;11(6):447-50 [483153.001]
  • [Cites] Bol Med Hosp Infant Mex. 1980 Jan-Feb;37(1):43-50 [7352968.001]
  • [Cites] Childs Nerv Syst. 2005 Jan;21(1):52-5 [15365745.001]
  • [Cites] Radiologe. 1992 Jul;32(7):333-9 [1509031.001]
  • [Cites] Vojnosanit Pregl. 1994 Mar-Apr;51(2):158-61 [8560829.001]
  • [Cites] Nephrol Dial Transplant. 1997 Jun;12(6):1143-8 [9198042.001]
  • [Cites] Zentralbl Neurochir. 1986;47(2):161-6 [3765965.001]
  • [Cites] Neurol India. 2003 Jun;51(2):269-70 [14571024.001]
  • [Cites] Am Surg. 1988 Jan;54(1):50-5 [3276260.001]
  • [Cites] An Esp Pediatr. 1988 Jun;28(6):565-8 [3057973.001]
  • [Cites] An Esp Pediatr. 1990 Apr;32(4):325-8 [2368996.001]
  • [Cites] Surg Gynecol Obstet. 1983 Apr;156(4):473-8 [6836464.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 2001 Jun;11(3):167-70 [11441995.001]
  • [Cites] Surg Neurol. 1998 Feb;49(2):127-34; discussion 134-5 [9457261.001]
  • [Cites] Childs Nerv Syst. 1993 Aug;9(5):253-5 [8252512.001]
  • [Cites] J Korean Med Sci. 1995 Feb;10(1):62-5 [7598828.001]
  • (PMID = 17333209.001).
  • [ISSN] 0256-7040
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


77. Euscher ED, Malpica A, Deavers MT, Silva EG: Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps. Am J Surg Pathol; 2005 Aug;29(8):1074-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps.
  • Although differential WT-1 expression between ovarian and uterine serous carcinoma has been discussed in the literature, there have been no studies of WT-1 expression in serous carcinomas in the peritoneum with or without concurrent serous carcinoma in an endometrial polyp.
  • Nine peritoneal serous carcinomas with coexistent serous carcinoma in an endometrial polyp, 10 peritoneal serous carcinomas without serous carcinoma in an endometrial polyp, 9 uterine serous carcinomas, and 12 ovarian serous carcinomas were stained with antibody to WT-1.
  • Ninety-two percent of ovarian serous carcinomas and 80% of peritoneal serous carcinomas without serous carcinoma involving an endometrial polyp expressed WT-1.
  • In contrast, 12% of peritoneal serous carcinomas with serous carcinoma in an endometrial polyp expressed WT-1 with the serous carcinoma in the endometrial polyp staining concordantly.
  • Peritoneal serous carcinomas without coexistent serous carcinoma in an endometrial polyp have a WT-1 expression pattern similar to ovarian serous carcinoma while peritoneal serous carcinomas with coexistent serous carcinoma in an endometrial polyp have a staining pattern similar to uterine serous carcinoma.
  • Additionally, the difference in WT-1 expression between peritoneal serous carcinomas with and without coexistent serous carcinoma in endometrial polyps suggests that peritoneal serous carcinoma may have different pathogenetic pathways.
  • [MeSH-major] Cystadenocarcinoma, Serous / chemistry. Endometrial Neoplasms / chemistry. Neoplasms, Second Primary / chemistry. Peritoneal Neoplasms / chemistry. Polyps / chemistry. WT1 Proteins / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Am J Surg Pathol. 2006 Jul;30(7):921; author reply 921-2 [16819342.001]
  • (PMID = 16006803.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / WT1 Proteins
  •  go-up   go-down


78. Kondi-Pafiti A, Kairi-Vassilatoul E, Spanidou-Carvouni H, Kontogianni-Katsarou K, Anastassopoulos G, Papadias K, Smyrniotis V: Extragenital cystic lesions of peritoneum, mesentery and retroperitoneum of the female. Clinicopathological characteristics of 19 cases. Eur J Gynaecol Oncol; 2005;26(3):323-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extragenital cystic lesions of peritoneum, mesentery and retroperitoneum of the female. Clinicopathological characteristics of 19 cases.
  • The clinicopathological characteristics are presented of 19 extragenital cystic lesions of female patients located at the retroperitoneum (9 cases), the mesentery (6 cases) and the peritoneum (4 cases).
  • Of the cases 18/19 were benign lesions and one case was a borderline mucinous cystic tumor.
  • [MeSH-major] Biomarkers, Tumor / analysis. Peritoneal Diseases / diagnosis
  • [MeSH-minor] Adult. Aged. Cysts. Female. Humans. Mesentery. Middle Aged. Peritoneum. Retroperitoneal Space

  • MedlinePlus Health Information. consumer health - Peritoneal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15991537.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


79. Nakao M, Oguri T, Maeno K, Ota C, Takakuwa O, Iwashima Y, Miyazaki M, Kutsuna T, Nakamura A, Sato S, Ueda R: Endobronchial metastasis from primary papillary serous carcinoma of the peritoneum. Intern Med; 2009;48(13):1165-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endobronchial metastasis from primary papillary serous carcinoma of the peritoneum.
  • Chest computed tomography (CT) showed an endobronchial tumor of the left main to the lower bronchus, atelectasis of the left lower lobe, and mediastinal shift.
  • Bronchoscopy revealed a polypoid tumor at the distal portion of the left main bronchus that occluded the bronchus.
  • Biopsy specimens from the endobronchial tumor were shown to be serous papillary adenocarcinoma.
  • Since the patient had been treated surgically for primary papillary serous carcinoma of the peritoneum (PSCP) 10 years earlier, immunohistochemical examinations were performed.
  • The diagnosis of endobronchial metastasis of PSCP was confirmed by immunohistochemical staining with cancer antigen 125 (CA125), vimentin, and Wilms tumor-1 (WT-1).
  • [MeSH-major] Bronchial Neoplasms / secondary. Cystadenocarcinoma, Papillary / secondary. Peritoneal Neoplasms

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19571452.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / CA-125 Antigen; 0 / Vimentin; 0 / WT1 Proteins
  •  go-up   go-down


80. Osada S, Hamada C, Shimaoka T, Kaneko K, Horikoshi S, Tomino Y: Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients. Nephrol Dial Transplant; 2009 Nov;24(11):3504-12
Hazardous Substances Data Bank. HYALURONIC ACID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients.
  • BACKGROUND: Proteoglycans (PGs) are dominant extracellular matrices (ECMs) in the peritoneal tissues.
  • Human peritoneal mesothelial cells synthesize small proteoglycans including decorin.
  • Peritonitis and long-term peritoneal dialysis (PD) cause fibrotic changes in the peritoneum that result in ECM remodelling and PG synthesis.
  • METHODS: Twenty-five peritoneal tissues from eight patients at initiation of PD, five long-term PD (>6 years) patients with severe peritonitis lasting for almost 1 month, nine patients after long-term PD (>6 years) without peritonitis and three normal subjects were included in the present study.
  • In long-term PD patients, the expression of versican was observed in their fibrotic-thickened peritoneum.
  • Versican was present in fibrous regions, elastic lamina of the peritoneum, vascular walls and perivascular regions.
  • Hyaluronan was observed in the whole thickened peritoneum, but its distribution differed in part from that of versican.
  • Alfa SMA-positive cells, namely 'myofibroblasts' and CD68-positive cells, i.e. macrophages, were observed in the fibrotic-thickened peritoneum of long-term PD patients.
  • Expressions of MMP-2, hyaluronan, SMA and CD68 in the peritoneum were marked in long-term PD patients' samples, which were strongly immunostained by versican, and were especially high in peritonitis patients.
  • CONCLUSIONS: It appears that alterations in PGs, including marked induction of versican with peritonitis and disappearance of decorin, are involved in peritoneal remodelling in PD patients.
  • These observations suggest that the alteration in PG components following PD therapy and severe inflammation contribute to fibrous thickening of the peritoneum.
  • [MeSH-major] Peritoneal Dialysis. Peritoneum / chemistry. Proteoglycans / analysis. Uremia / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Nephrol Dial Transplant. 2009 Nov;24(11):3271-3 [19833665.001]
  • (PMID = 19542195.001).
  • [ISSN] 1460-2385
  • [Journal-full-title] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • [ISO-abbreviation] Nephrol. Dial. Transplant.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / ACTA2 protein, human; 0 / Actins; 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD68 antigen, human; 0 / DCN protein, human; 0 / Decorin; 0 / Extracellular Matrix Proteins; 0 / Proteoglycans; 0 / VCAN protein, human; 126968-45-4 / Versicans; 9004-61-9 / Hyaluronic Acid; EC 3.4.24.24 / Matrix Metalloproteinase 2
  •  go-up   go-down


81. Malomo OO, Kuti O, Orji EO, Ogunniyi SO, Sule SS: A randomised controlled study of non-closure of peritoneum at caesarean section in a Nigerian population. J Obstet Gynaecol; 2006 Jul;26(5):429-32
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A randomised controlled study of non-closure of peritoneum at caesarean section in a Nigerian population.
  • A prospective randomised study of 54 patients undergoing caesarean section was carried out to determine if non-closure of peritoneum at lower segment caesarean section has advantages over suture peritonisation with regard to postoperative morbidity.
  • A total of 27 women were randomised to closure and 27 to non-closure of peritoneum.
  • The results revealed that anaesthesia and operating times were significantly shorter in patients that had the peritoneum left open.
  • The study concludes that non-closure of peritoneum is associated with significantly reduced operation and anaesthesia time with a non-significant difference in immediate postoperative outcome.
  • Non-closure of peritoneum should be adopted at caesarean delivery.
  • [MeSH-major] Cesarean Section / methods. Peritoneum / surgery. Sutures

  • MedlinePlus Health Information. consumer health - Cesarean Section.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Obstet Gynaecol. 2007 Feb;27(2):232 [17454497.001]
  • (PMID = 16846869.001).
  • [ISSN] 0144-3615
  • [Journal-full-title] Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
  • [ISO-abbreviation] J Obstet Gynaecol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial
  • [Publication-country] England
  •  go-up   go-down


82. Zhang KD, Guo XN, Yang L, Zhang DT, Bai FH, Jiang HP, Zhai HH, Nie YZ, Wu KC, Fan DM: [Screening and identification of phage-displayed polypeptides specifically binding to human gastric cancer with high metastatic potential to peritoneum]. Zhonghua Zhong Liu Za Zhi; 2005 Jul;27(7):397-400
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Screening and identification of phage-displayed polypeptides specifically binding to human gastric cancer with high metastatic potential to peritoneum].
  • OBJECTIVE: By means of phage-display technique, to screen polypeptides that specifically bind to human gastric cancer with high metastatic potential to peritoneum.
  • METHODS: Two human gastric cancer cell lines were used: GC9811-P with high metastatic potential to peritoneum and its wild type parental GC9811, to carry out subtractive screening with a phage display-12 peptide library.
  • When injected into the peritoneal cavity of nude mice, 6 of the 40 clones did not bind to mouse peritoneum as examined by immunohistochemical staining.
  • CONCLUSION: Two peptides have been obtained that specifically bind to a gastric cancer cell variant GC9811-P, which easily disseminates to the peritoneum.
  • Whether or not they could block GC9811-P metastasis to peritoneum in vivo remains to be determined.
  • [MeSH-major] Peptide Library. Peptides / metabolism. Peritoneal Neoplasms / secondary. Stomach Neoplasms / pathology
  • [MeSH-minor] Animals. Binding Sites. Cell Line, Tumor. Enzyme-Linked Immunosorbent Assay. Female. Humans. Male. Mice. Mice, Inbred BALB C. Protein Array Analysis / methods. Protein Binding. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Metastatic cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16188121.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Peptide Library; 0 / Peptides
  •  go-up   go-down


83. Chan TM, Yung S: Studying the effects of new peritoneal dialysis solutions on the peritoneum. Perit Dial Int; 2007 Jun;27 Suppl 2:S87-93
Hazardous Substances Data Bank. GLUCOSE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Studying the effects of new peritoneal dialysis solutions on the peritoneum.
  • BACKGROUND: Compelling data underscore the bioincompatible nature of glucose-based peritoneal dialysis (PD) solutions and their detrimental effects on peritoneal physiology and morphology.
  • New PD solutions have been formulated to tackle common clinical problems such as inadequate ultrafiltration or malnutrition, and to improve biocompatibility-the latter aimed at preserving the structural and functional integrity of the peritoneum and reducing adverse systemic effects on the patient.
  • METHODS: This article reviews the factors in PD fluids that alter normal peritoneal anatomy and physiology, and the data that illustrate approaches to investigating the local and systemic biocompatibility of new PD solutions.
  • RESULTS: Chronic exposure of the peritoneal membrane to glucose-based PD solutions results in denudation of the mesothelium, thickened submesothelium, and hyalinization of the vasculature, often resulting in reduced or lost solute and water clearance.
  • Clinical studies are ongoing to assess the impact of the new PD fluids on peritoneal function, morbidity, and mortality.
  • [MeSH-major] Dialysis Solutions / chemistry. Peritoneal Dialysis. Peritoneum / drug effects

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17556337.001).
  • [ISSN] 0896-8608
  • [Journal-full-title] Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
  • [ISO-abbreviation] Perit Dial Int
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Amino Acids; 0 / Bicarbonates; 0 / Biocompatible Materials; 0 / Buffers; 0 / Dialysis Solutions; 0 / Glucans; 0 / icodextrin; IY9XDZ35W2 / Glucose
  • [Number-of-references] 43
  •  go-up   go-down


84. Lobo VL, Soares JM Jr, de Jesus Simões M, Simões Rdos S, de Lima GR, Baracat EC: Does gestrinone antagonize the effects of estrogen on endometrial implants upon the peritoneum of rats? Clinics (Sao Paulo); 2008 Aug;63(4):525-30
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does gestrinone antagonize the effects of estrogen on endometrial implants upon the peritoneum of rats?
  • METHODS: Uterine transplants were attached to the peritoneum of female Wistar rats via a surgical autotransplantation technique.
  • CONCLUSION: Our findings suggest that gestrinone antagonizes estrogen's effects on rat peritoneal endometrial implants.

  • MedlinePlus Health Information. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Endocrinol. 1998 Feb;138(2):216-26 [9506869.001]
  • [Cites] Clinics (Sao Paulo). 2007 Oct;62(5):553-60 [17952314.001]
  • [Cites] Clin Exp Obstet Gynecol. 1999;26(3-4):158-61 [10668143.001]
  • [Cites] Toxicol Sci. 2001 May;61(1):68-75 [11294976.001]
  • [Cites] Climacteric. 2001 Jun;4(2):110-9 [11428175.001]
  • [Cites] Horm Res. 2001;56 Suppl 1:82-5 [11786692.001]
  • [Cites] Gynecol Obstet Invest. 2002;53 Suppl 1:2-11 [11834862.001]
  • [Cites] Climacteric. 2000 Sep;3(3):176-82 [11910619.001]
  • [Cites] Ann N Y Acad Sci. 2002 Mar;955:89-100; discussion 118, 396-406 [11949968.001]
  • [Cites] Drug Saf. 2002;25(11):759-79 [12222988.001]
  • [Cites] Gynecol Obstet Invest. 2002;54(4):185-90 [12592059.001]
  • [Cites] Fertil Steril. 2004 Sep;82(3):673-8 [15374713.001]
  • [Cites] Obes Rev. 2004 Nov;5(4):197-216 [15458395.001]
  • [Cites] Acta Endocrinol (Copenh). 1984 Jun;106(2):282-8 [6428124.001]
  • [Cites] Isr J Med Sci. 1984 Nov;20(11):1094-6 [6511341.001]
  • [Cites] Fertil Steril. 1985 Nov;44(5):684-94 [4054348.001]
  • [Cites] Fertil Steril. 1990 May;53(5):921-5 [2332064.001]
  • [Cites] Endocrinology. 1990 Jun;126(6):3263-7 [2351116.001]
  • [Cites] Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1679-84 [2122726.001]
  • [Cites] Fertil Steril. 1991 Feb;55(2):403-10 [1991538.001]
  • [Cites] Gen Pharmacol. 1991;22(3):505-10 [1869024.001]
  • [Cites] Fertil Steril. 1993 Jan;59(1):232-5 [8419213.001]
  • [Cites] Baillieres Clin Obstet Gynaecol. 1993 Dec;7(4):813-38 [8131317.001]
  • [Cites] Drug Saf. 1994 Aug;11(2):104-13 [7945998.001]
  • [Cites] Reprod Toxicol. 1995 May-Jun;9(3):233-8 [7579907.001]
  • [Cites] Zhonghua Fu Chan Ke Za Zhi. 1995 Dec;30(12):735-7 [8728919.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1996 Jul;67(1):35-40 [8789747.001]
  • [Cites] Semin Reprod Endocrinol. 1997;15(3):285-90 [9383837.001]
  • [Cites] J Steroid Biochem Mol Biol. 1997 Sep-Oct;63(1-3):75-80 [9449208.001]
  • [Cites] J Invest Surg. 2005 Jul-Aug;18(4):177-83 [16126628.001]
  • [Cites] Clin Exp Obstet Gynecol. 2006;33(2):85-9 [16903243.001]
  • [Cites] Hum Reprod Update. 2006 Sep-Oct;12(5):641-9 [16775193.001]
  • [Cites] Ceska Gynekol. 1998 Nov;63(6):453-6 [10535167.001]
  • (PMID = 18719766.001).
  • [ISSN] 1807-5932
  • [Journal-full-title] Clinics (São Paulo, Brazil)
  • [ISO-abbreviation] Clinics (Sao Paulo)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Estrogen Antagonists; 0 / Estrogens; 0 / Progestins; 1421533RCM / Gestrinone
  • [Other-IDs] NLM/ PMC2664131
  •  go-up   go-down


85. Barberini F, Zani A, Ripani M, Di Nitto V, Brunone F: The complex arrangement of an "aorto-jejunal paraduodenal" fossa, as revealed by dissection of human posterior parietal peritoneum. Ann Anat; 2007;189(3):299-303
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The complex arrangement of an "aorto-jejunal paraduodenal" fossa, as revealed by dissection of human posterior parietal peritoneum.
  • Peritoneal fossae derive from normal or anomalous coalescence of the peritoneum during fetal development, or from the course of retroperitoneal vessels.
  • In this report from an autopsy, a singular peritoneal fossa was delimited superiorly by an arcuate serous fold, raised up by the inferior mesenteric vein, and infero-posteriorly by two (right and left) avascular folds, extending from the abdominal aorta to the jejunum.
  • [MeSH-major] Aorta, Abdominal / anatomy & histology. Duodenum / blood supply. Jejunum / blood supply. Peritoneum / anatomy & histology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17534040.001).
  • [ISSN] 0940-9602
  • [Journal-full-title] Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft
  • [ISO-abbreviation] Ann. Anat.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


86. Hassa H, Tanir HM, Tekin B, Artan S, Dundar E, Kirilmaz SD, Sahin Mutlu F: Apoptosis patterns in eutopic and ectopic endometrium, adhesions and normal-looking peritoneum from women with or without endometriosis. Arch Gynecol Obstet; 2009 Aug;280(2):195-9
MedlinePlus Health Information. consumer health - Endometriosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Apoptosis patterns in eutopic and ectopic endometrium, adhesions and normal-looking peritoneum from women with or without endometriosis.
  • OBJECTIVE: To assess the apoptosis rate in eutopic and ectopic endometrial stromal and glandular cells, normal peritoneum and adhesions in women with endometriosis.
  • Normal-looking peritoneum, peritoneal implants and adhesions were sampled and fixed in formaldehyde for immunohistochemical staining with Bcl-2 and Bax.
  • RESULTS: The intensity of Bax staining of normal-looking peritoneum in early staged endometriosis was higher, compared to women with late-staged and women without endometriosis (P = 0.03).
  • Number of cells with positive apoptotic signals assessed via TUNEL (P = 1.0) and M30 cytoDEATH antibody (P = 0.59) in normal-looking peritoneum did not differ between three groups.
  • [MeSH-minor] Adult. Case-Control Studies. Female. Humans. Peritoneum / metabolism. Tissue Adhesions / metabolism. Young Adult

  • Genetic Alliance. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19112572.001).
  • [ISSN] 1432-0711
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Proto-Oncogene Proteins c-bcl-2; 0 / bcl-2-Associated X Protein
  •  go-up   go-down


87. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA, Kelly MM: Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol; 2005 Feb;16(2):425-36
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.
  • Epithelial mesenchymal transition (EMT), a process involved in many growth and repair functions, has been identified in the peritoneal tissues of patients who undergo peritoneal dialysis.
  • The sequence of changes in gene regulation and cellular events associated with EMT after TGF-beta1-induced peritoneal fibrosis is reported.
  • Peritoneal effluent and tissue were analyzed for markers of EMT.
  • These findings suggest that EMT occurs in vivo after TGF-beta1 overexpression in the peritoneum.
  • This further supports the central role of TGF-beta1 in peritoneal fibrosis and provides an important model to study the sequence of events involved in TGF-beta1-induced EMT.
  • [MeSH-major] Mesoderm / pathology. Peritoneum / pathology. Peritonitis / pathology. Transforming Growth Factor beta / pharmacology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15590759.001).
  • [ISSN] 1046-6673
  • [Journal-full-title] Journal of the American Society of Nephrology : JASN
  • [ISO-abbreviation] J. Am. Soc. Nephrol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / RNA, Messenger; 0 / Tgfb1 protein, rat; 0 / Transforming Growth Factor beta; 0 / Transforming Growth Factor beta1
  •  go-up   go-down


88. Liu Y, Hou QX: [Effect of carbon dioxide pneumoperitoneum during laparoscopic surgery on morphology of peritoneum]. Zhonghua Yi Xue Za Zhi; 2006 Jan 17;86(3):164-6
Hazardous Substances Data Bank. Carbon dioxide .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect of carbon dioxide pneumoperitoneum during laparoscopic surgery on morphology of peritoneum].
  • OBJECTIVE: To investigate the influence of carbon dioxide (CO2) pneumoperitoneum during laparoscopic surgery on morphology of peritoneum.
  • Specimens of parietal peritoneum were obtained at different time points, 0, 30, 90, and 120 min after the beginning of observation, i.e. e, insufflation or opening of the peritoneal cavity, to undergo transmission electron microscopy and scanning electron microscopy to observe the morphological changes of mesothelial cells.
  • CONCLUSION: Carbon dioxide pneumoperitoneum during laparoscopic surgery causes significant morphological changes in the peritoneum duration of insufflation dependently.
  • [MeSH-minor] Female. Humans. Microscopy, Electron. Ovarian Cysts / surgery. Peritoneum / drug effects. Peritoneum / pathology. Peritoneum / ultrastructure. Uterine Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16638321.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Randomized Controlled Trial
  • [Publication-country] China
  • [Chemical-registry-number] 142M471B3J / Carbon Dioxide
  •  go-up   go-down


89. Barone RJ, Campora MI, Gimenez NS, Ramirez L, Santopietro M, Grbavac D, Pattin M, Panese SA: Peritoneum: a noble membrane in long-term dialysis treatment. Adv Perit Dial; 2009;25:80-4
Hazardous Substances Data Bank. UREA .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peritoneum: a noble membrane in long-term dialysis treatment.
  • The durability of the peritoneum as a dialysis membrane is as yet an unanswered question.
  • To evaluate survival of the peritoneum for dialysis, we analyzed peritoneal failure related to technique dropout because of peritonitis, inadequate dialysis, and ultrafiltration disorders.
  • We retrospectively analyzed data for 89 peritoneal dialysis patients who had been treated for at least 3 months [52 women, 37 men; mean age: 50.91 +/- 13.72 years (range: 22 - 81 years)] from August 4, 1993, to July 1, 2008.
  • The Kaplan-Meier method was used to measure peritoneum survival, with only a definitive switch to hemodialysis or death from peritonitis, ultrafiltration failure, or inadequate dialysis as endpoints.
  • Peritoneum survival was 98.8%, 93.7%, 87.6%, 66.9%, 46.4%, and 33.8% at 1, 3, 5, 8, 10, and 14 years.
  • In the 15 years of our program, peritoneum failure represented less than 1.5% of drop-out causes annually.
  • The peritoneum is a reliable membrane to reach dialysis targets in long-term therapy.
  • [MeSH-major] Peritoneal Dialysis. Peritoneum / physiopathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19886323.001).
  • [ISSN] 1197-8554
  • [Journal-full-title] Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
  • [ISO-abbreviation] Adv Perit Dial
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 8W8T17847W / Urea; AYI8EX34EU / Creatinine
  •  go-up   go-down


90. Zarogiannis S, Vogiatzidis K, Hatzoglou C, Liakopoulos V, Potamianos S, Eleftheriadis T, Dovas S, Kourti P, Gourgoulianis K, Molyvdas PA, Stefanidis I: mu-Opioid stimulation of isolated parietal sheep peritoneum decreases peritoneal permeability in vitro. Adv Perit Dial; 2007;23:34-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] mu-Opioid stimulation of isolated parietal sheep peritoneum decreases peritoneal permeability in vitro.
  • The peritoneal mesothelium is one of the main barriers to ion transport in peritoneal dialysis.
  • In the present study, we used Ussing chamber experiments to investigate the effect of morphine on the transmesothelial electrical resistance (RTM) of isolated parietal sheep peritoneum.
  • Peritoneal samples from the diaphragm of adult sheep were isolated directly after the death of the animals and were transferred to the laboratory within 30 minutes in a cooled Krebs-Ringer bicarbonate solution (4 degrees C, pH 7.5) bubbled with 95% O2/5% CO2.
  • A planar sheet of parietal peritoneum was mounted in an Ussing-type chamber and morphine (10(-9) mol/L) was added apically and basolaterally.
  • The RTM is an established surrogate of peritoneal permeability.
  • The results of the present study indicate rapid action of basolaterally added morphine on the permeability of the parietal peritoneum.
  • The observed increase in the RTM indicates the existence in the parietal peritoneum of micro-opioid receptors that seem to prevail basolaterally.
  • [MeSH-major] Morphine / pharmacology. Peritoneum / metabolism. Receptors, Opioid, mu / metabolism
  • [MeSH-minor] Animals. Female. In Vitro Techniques. Ion Transport. Male. Peritoneal Dialysis. Permeability. Sheep, Domestic

  • Hazardous Substances Data Bank. MORPHINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17886599.001).
  • [ISSN] 1197-8554
  • [Journal-full-title] Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
  • [ISO-abbreviation] Adv Perit Dial
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Receptors, Opioid, mu; 76I7G6D29C / Morphine
  •  go-up   go-down


91. Erikoglu M, Yol S, Avunduk MC, Erdemli E, Can A: Electron-microscopic alterations of the peritoneum after both cold and heated carbon dioxide pneumoperitoneum. J Surg Res; 2005 May 1;125(1):73-7
Hazardous Substances Data Bank. Carbon dioxide .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Electron-microscopic alterations of the peritoneum after both cold and heated carbon dioxide pneumoperitoneum.
  • In this study, we aimed to examine the electron and light microscopic alterations of the peritoneum after both cold-dry and heated-humidified CO(2) pneumoperitoneum.
  • In groups II and III, peritoneal gas was emptied 2 h after pneumoperitoneum application.
  • Peritoneal samples were examined both by scanning electron and light microscopy by two different pathologists who were not aware of the groups.
  • According to scanning electron microscopic examination, in group I, normal peritoneum was covered by a sheet of flat mesothelial cells densely covered with microvilli.
  • CONCLUSIONS: Electron and light microscopic examination revealed that heated-humidified CO(2) results in less peritoneal alteration than cold-dry CO(2.
  • [MeSH-major] Carbon Dioxide. Peritoneum / ultrastructure. Pneumoperitoneum, Artificial

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15836853.001).
  • [ISSN] 0022-4804
  • [Journal-full-title] The Journal of surgical research
  • [ISO-abbreviation] J. Surg. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 142M471B3J / Carbon Dioxide
  •  go-up   go-down


92. Albanese AM, Albanese EF, Miño JH, Gómez E, Gómez M, Zandomeni M, Merlo AB: Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas. Surg Radiol Anat; 2009 Jun;31(5):369-77
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas.
  • BACKGROUND: We have not found studies that have measured the peritoneal surface area of each of the walls, organs, mesos, omenta, and peritoneal ligaments in a group of non-eviscerated human cadavers.
  • (1) the surface values of walls, organs, mesos, omenta, and peritoneal ligaments of each one and all the areas mentioned in the anatomy bibliography and their contribution to supra- and infra-colic portions, visceral and parietal portions of the supra- and infra-colic portions and the total peritoneal surface area, and (2) the relationship between the peritoneal surface values by direct measurement and the values obtained applying the formulas usually used in clinical practice to obtain body surface area.
  • METHODS: The peritoneal surface area of ten female human bodies presenting no abdominal pathologies were measured.
  • RESULTS: This paper provides for the first time data on each one and all the areas covered by the peritoneum.
  • The total peritoneal surface area was (mean +/- SE) 14,323.62 +/- 824.37 cm(2).
  • The two greater surfaces of peritoneum (39.21% of the total surface) correspond to the jejunum-ileum and its mesentery.
  • The diaphragmatic peritoneum represented the greater area of parietal peritoneum.
  • An interesting result of this work is that the surface of the parietal peritoneum in the supracolic abdomen (1,786.67 +/- 92.58 cm(2), 68.56%) is more than twice that of the infracolic region (756.62 +/- 55.91 cm(2), 31.44%).
  • The visceral peritoneal surface (81.89 +/- 0.99% of the total) was much higher than that of the parietal peritoneum (18.11 +/- 0.99%).
  • The peritoneal surface area measured in this study in non-eviscerated cadavers represents more than 96% of the one estimated by the above-mentioned formulas.
  • CONCLUSION: The values shown in this paper would provide non-existing information for basic anatomy, and would contribute either to the study of pathologies involving the peritoneum or to their diagnosis and therapies.
  • [MeSH-major] Peritoneum / anatomy & histology. Viscera / anatomy & histology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nutrition. 1989 Sep-Oct;5(5):303-11; discussion 312-3 [2520314.001]
  • [Cites] Adv Perit Dial. 1996;12:3-6 [8865861.001]
  • [Cites] Eur J Surg Oncol. 2006 Aug;32(6):682-5 [16631341.001]
  • [Cites] J Pediatr. 1978 Jul;93(1):62-6 [650346.001]
  • [Cites] J Am Soc Nephrol. 1999 Feb;10(2):342-6 [10215334.001]
  • [Cites] Surg Radiol Anat. 2000;22(3-4):135-8 [11143303.001]
  • [Cites] N Engl J Med. 1987 Oct 22;317(17):1098 [3657876.001]
  • [Cites] AJR Am J Roentgenol. 2006 May;186(5):1368-79 [16632733.001]
  • [Cites] Contrib Nephrol. 2006;150:13-9 [16720986.001]
  • [Cites] Abdom Imaging. 2005 May-Jun;30(3):361-8 [15688110.001]
  • [Cites] Radiol Med. 1991 May;81(5):656-9 [2057592.001]
  • [Cites] Cancer Chemother Rep. 1970 Aug;54(4):225-35 [5527019.001]
  • [Cites] Perit Dial Int. 1989;9(2):135-41 [2488200.001]
  • [Cites] Int J Artif Organs. 2007 Jun;30(6):501-12 [17628851.001]
  • [Cites] J Am Coll Surg. 2006 Jan;202(1):100-11 [16377503.001]
  • [Cites] Am J Med Sci. 1988 May;295(5):453-8 [3287918.001]
  • [Cites] J Am Soc Nephrol. 2001 Oct;12(10):2139-45 [11562413.001]
  • [Cites] Cancer Metastasis Rev. 2003 Dec;22(4):465-72 [12884919.001]
  • [Cites] World J Surg. 2006 Dec;30(12):2170-81 [17102920.001]
  • [Cites] Perit Dial Int. 1997 Jan-Feb;17(1):72-9 [9068026.001]
  • [Cites] Perit Dial Int. 2007 Jun;27 Suppl 2:S82-6 [17556336.001]
  • [Cites] Adv Perit Dial. 2005;21:17-20 [16686278.001]
  • [Cites] J Am Soc Nephrol. 2002 Jan;13(1):197-203 [11752038.001]
  • (PMID = 19142561.001).
  • [ISSN] 1279-8517
  • [Journal-full-title] Surgical and radiologic anatomy : SRA
  • [ISO-abbreviation] Surg Radiol Anat
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


93. García-Graz NJ, Galindo-Ibarra JL, García-Soto G, Mejía-Arreguín H, Trejo-Suárez J, Ramírez-Salas MA: [Vascular graft of aponeurosis with peritoneum in dogs]. Cir Cir; 2008 May-Jun;76(3):235-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Vascular graft of aponeurosis with peritoneum in dogs].
  • [Transliterated title] Injerto vascular de aponeurosis con peritoneo en perros.
  • A 4-cm vascular autograft was created with the posterior rectus aponeurosis with subjacent peritoneum, leaving the second one as the internal sheath.
  • [MeSH-major] Aorta, Abdominal / surgery. Connective Tissue / transplantation. Peritoneum / transplantation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18647557.001).
  • [ISSN] 0009-7411
  • [Journal-full-title] Cirugía y cirujanos
  • [ISO-abbreviation] Cir Cir
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


94. Ayhan A, Basaran A, Güler TO: Effects of oxidized regenerated methylcellulose on lymphocyst formation and peritoneum in gynecologic cancer patients. Int J Gynecol Cancer; 2010 Jan;20(1):23-7
Hazardous Substances Data Bank. METHYL CELLULOSE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of oxidized regenerated methylcellulose on lymphocyst formation and peritoneum in gynecologic cancer patients.
  • Oxidized regenerated methylcellulose use does not affect the duration of drains, hence ORC does not seem to pose a stimulatory effect on the peritoneum.
  • [MeSH-major] Carcinoma / surgery. Cellulose, Oxidized / pharmacology. Genital Neoplasms, Female / surgery. Lymphocele / prevention & control. Methylcellulose / pharmacology. Peritoneum / drug effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20130499.001).
  • [ISSN] 1525-1438
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cellulose, Oxidized; 82347-53-3 / Surgicel; 9004-67-5 / Methylcellulose
  •  go-up   go-down


95. Griffith JS, Binkley PA, Kirma NB, Schenken RS, Witz CA, Tekmal RR: Imatinib decreases endometrial stromal cell transmesothial migration and proliferation in the extracellular matrix of modeled peritoneum. Fertil Steril; 2010 Dec;94(7):2531-5
Hazardous Substances Data Bank. IMATINIB MESYLATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imatinib decreases endometrial stromal cell transmesothial migration and proliferation in the extracellular matrix of modeled peritoneum.
  • OBJECTIVE: To characterize imatinib's effect on endometrial stromal cell (ESC) attachment, proliferation, and invasion in modeled peritoneum.
  • CONCLUSION(S): Imatinib treatment reduces ESC proliferation and invasion in modeled peritoneum without altering attachment.
  • [MeSH-major] Cell Proliferation / drug effects. Endometrium / drug effects. Extracellular Matrix / drug effects. Peritoneum / drug effects. Piperazines / pharmacology. Pyrimidines / pharmacology. Stromal Cells / drug effects. Transendothelial and Transepithelial Migration / drug effects

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20553674.001).
  • [ISSN] 1556-5653
  • [Journal-full-title] Fertility and sterility
  • [ISO-abbreviation] Fertil. Steril.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / P01 HD035276; United States / NICHD NIH HHS / HD / R01 HD049637
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate
  •  go-up   go-down


96. Bastos EL, Fagundes DJ, Taha MO, Novo NF, Juliano Y, Simões Mde J, Silvado RA: The role of bovine preserved peritoneum in rats ventral hernia: a histological evaluation. Acta Cir Bras; 2006 Sep-Oct;21(5):328-31
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The role of bovine preserved peritoneum in rats ventral hernia: a histological evaluation.
  • PURPOSE: To assess the role of preserved bovine parietal peritoneum as a material for hernia repair in a rat ventral hernia model.
  • Control animals (n=20) had the polypropylene (PP) mesh sutured into the defect, whereas bovine preserved peritoneum (BPP) was used in experimental group (n=20).

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16981037.001).
  • [ISSN] 0102-8650
  • [Journal-full-title] Acta cirurgica brasileira
  • [ISO-abbreviation] Acta Cir Bras
  • [Language] ENG
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Biocompatible Materials; 0 / Polypropylenes; 9007-34-5 / Collagen
  •  go-up   go-down


97. Liakopoulos V, Zarogiannis S, Hatzoglou C, Kourti P, Poultsidi A, Eleftheriadis T, Gourgoulianis K, Molyvdas PA, Stefanidis I: Inhibition by mercuric chloride of aquaporin-1 in the parietal sheep peritoneum: an electrophysiologic study. Adv Perit Dial; 2006;22:7-10
Hazardous Substances Data Bank. MERCURIC CHLORIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inhibition by mercuric chloride of aquaporin-1 in the parietal sheep peritoneum: an electrophysiologic study.
  • The peritoneal mesothelium is a barrier to ion transport in peritoneal dialysis.
  • In this study, we used Ussing-chamber experiments to investigate the effect of HgCl2, an aquaporin-1 inhibitor, on the transmesothelial electrical resistance (RTM) of isolated sheep parietal peritoneum.
  • Peritoneal samples from the diaphragm of adult sheep were isolated immediately after the death of the animal and were transferred within 30 minutes to the laboratory in a cooled Krebs-Ringer bicarbonate solution (4 degrees C, pH 7.5) bubbled with 95% O(2)/5% CO2.
  • A planar sheet of the parietal peritoneum was mounted in an Ussing-type chamber and HgCl2 (10(-4) mol/L) was added apically or basolaterally.
  • In the present study, rapid action of HgCl2 on the permeability ofthe parietal peritoneum was observed, resulting in a reduction in the RTM Taken together, these findings indicate that inhibition of aquaporin-1 alters the ionic permeability of the parietal peritoneal membrane.
  • [MeSH-major] Aquaporin 1 / antagonists & inhibitors. Mercuric Chloride / pharmacology. Peritoneum / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16983930.001).
  • [ISSN] 1197-8554
  • [Journal-full-title] Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
  • [ISO-abbreviation] Adv Perit Dial
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 146410-94-8 / Aquaporin 1; 53GH7MZT1R / Mercuric Chloride
  •  go-up   go-down


98. Matsutani N, Takase B, Nogami Y, Ozeki Y, Ishihara M, Maehara T: The peritoneum as a novel oxygenation organ: revitalization of intraperitoneal oxygenation. Shock; 2008 Sep;30(3):250-3
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The peritoneum as a novel oxygenation organ: revitalization of intraperitoneal oxygenation.
  • To determine whether the peritoneal cavity can be used as a source of "extrapulmonary respiration," we perfused the peritoneal cavity with oxygenated red blood cells (RBCs) and saline, and measured the amount of oxygenation delivered through the peritoneum of dogs under controlled ventilation.
  • Inflow and outflow catheters were placed in the peritoneal cavity and connected to a perfusion circuit.
  • We investigated the safety of this procedure by examining the relationship between intraperitoneal infusion volume and hemodynamic changes in dogs that underwent peritoneal perfusion with oxygenated RBC (n = 6) and with oxygenated saline (n = 6).
  • The peritoneum can potentially serve as an "artificial lung" in critically ill patients.
  • [MeSH-major] Oxygen / chemistry. Oxygen / metabolism. Peritoneal Cavity. Peritoneum / metabolism

  • Hazardous Substances Data Bank. Carbon dioxide .
  • Hazardous Substances Data Bank. OXYGEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18197147.001).
  • [ISSN] 1540-0514
  • [Journal-full-title] Shock (Augusta, Ga.)
  • [ISO-abbreviation] Shock
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 142M471B3J / Carbon Dioxide; S88TT14065 / Oxygen
  •  go-up   go-down


99. Asghar S, Qureshi N, Awan A: Benign mesothelioma of peritoneum presenting as a pelvic mass. J Coll Physicians Surg Pak; 2008 Nov;18(11):723-5
MedlinePlus Health Information. consumer health - Pelvic Pain.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign mesothelioma of peritoneum presenting as a pelvic mass.
  • A large solitary multiloculated pelvic cyst in a 40-year-old woman with chronic pelvic pain was diagnosed to be a Multicystic Benign Mesothelioma (MBM) of peritoneum at laparotomy.
  • Operative findings showed dense adhesions between uterus and bladder anteriorly, small intestines and pouch of Douglas posteriorly, a right ovarian cyst cm containing clear serous fluid and two nodular deposits were seen in the pouch of Douglas, small multiple deposits was found over the mesentery of small intestine and parietal peritoneum.
  • [MeSH-major] Mesothelioma, Cystic / diagnosis. Ovarian Neoplasms / diagnosis. Pelvic Neoplasms / diagnosis. Pelvic Pain / diagnosis. Peritoneal Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18983801.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


100. Malvasi A, Tinelli A, Tinelli R, Serio G, Pellegrino M, Mettler L: Subfascial hematomas and hemoperitoneum after cesarean section: prevalence according to closure and non-closure of the parietal peritoneum. Gynecol Obstet Invest; 2008;66(3):162-8
MedlinePlus Health Information. consumer health - Cesarean Section.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Subfascial hematomas and hemoperitoneum after cesarean section: prevalence according to closure and non-closure of the parietal peritoneum.
  • AIM: To compare early hemorrhagic complications and the surgical and clinical outcome in the closure and non-closure of the parietal peritoneum in cesarean section (CS) patients.
  • MATERIAL AND METHODS: We retrospectively evaluated 2,576 post-CS women subdivided and compared in two groups by open and closed parietal peritoneum (group I, n = 1,580, group II, n = 996).
  • As the posterior surface of the Retzius space is open and if post-CS pathological bleeding occurs, blood can invade the peritoneal cavity causing a hemoperitoneum, with the possibility of hemorrhagic shock and a worse clinical outcome.
  • [MeSH-major] Cesarean Section / methods. Hematoma / etiology. Hemoperitoneum / etiology. Peritoneum / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2008 S. Karger AG, Basel.
  • (PMID = 18562796.001).
  • [ISSN] 1423-002X
  • [Journal-full-title] Gynecologic and obstetric investigation
  • [ISO-abbreviation] Gynecol. Obstet. Invest.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down






Advertisement